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RÉSUMÉ 
UNE EXPOSITION NÉONATALE À L’OXYGÈNE MÈNE À DES MODIFICATIONS DE LA FONCTION 
MITOCHONDRIALE CHEZ LE RAT ADULTE 
Introduction: L’exposition à l’oxygène (O2) des ratons nouveau-nés a des conséquences à l’âge 
adulte dont une hypertension artérielle (HTA), une dysfonction vasculaire, une néphropénie et des 
indices de stress oxydant. En considérant que les reins sont encore en développement actif lors 
des premiers jours après la naissance chez les rats, jouent un rôle clé dans le développement de 
l’hypertension et qu’une dysfonction mitochondriale est associé à une augmentation du stress 
oxydant, nous postulons que les conditions délétères néonatales peuvent avoir un impact 
significatif au niveau rénal sur la modulation de l’expression de protéines clés du fonctionnement 
mitochondrial et une production mitochondriale excessive d’espèces réactives de l’ O2.  
Méthodes: Des ratons Sprague-Dawley sont exposés à 80% d’O2 (H) ou 21% O2 (Ctrl) du 3
e au 10e jr 
de vie. En considérant que plusieurs organes des rats sont encore en développement actif à la 
naissance, ces rongeurs sont un modèle reconnu pour étudier les complications d’une hyperoxie 
néonatale, comme celles liées à une naissance prématurée chez l’homme.  À 4 et à 16 semaines, 
les reins sont prélevés et les mitochondries sont extraites suivant une méthode d’extraction 
standard, avec un tampon contenant du sucrose 0.32 M et différentes centrifugations. 
L’expression des protéines mitochondriales a été mesurée par Western blot, tandis que la 
production d’ H202 et les activités des enzymes clés du cycle de Krebs ont été évaluées par 
spectrophotométrie. Les résultats sont exprimés par la moyenne ± SD. 
Résultats: Les rats mâles H de 16 semaines (n=6) présentent une activité de citrate synthase 
(considéré standard interne de l’expression protéique et de l’abondance mitochondriales) 
augmentée (12.4 ± 8.4 vs 4.1 ± 0.5 μmole/mL/min), une diminution de l’activité d’aconitase 
(enzyme sensible au redox mitochondrial) (0.11 ± 0.05 vs 0.20 ± 0.04 μmoles/min/mg 
mitochondrie), ainsi qu’une augmentation dans la production de H202 (7.0 ± 1.3 vs 5.4 ± 0.8 
ρmoles/mg protéines mitochondriales) comparativement au groupe Ctrl (n=6 mâles et 4 femelles). 
Le groupe H (vs Ctrl) présente également une diminution dans l’expression de peroxiredoxin-3 
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(Prx3) (H 0.61±0.06 vs. Ctrl 0.78±0.02 unité relative, -23%; p<0.05), une protéine impliquée dans 
l’élimination d’ H202, de l’expression du cytochrome C oxidase (Complexe IV) (H 1.02±0.04 vs. Ctrl 
1.20±0.02 unité relative, -15%; p<0.05), une protéine de la chaine de respiration mitochondriale, 
tandis que l’expression de la protéine de découplage (uncoupling protein)-2 (UCP2), impliquée 
dans la dispersion du gradient proton, est significativement augmentée (H 1.05±0.02 vs. Ctrl 
0.90±0.03 unité relative, +17%; p<0.05). Les femelles H (n=6) (vs Ctrl, n=6) de 16 semaines 
démontrent une augmentation significative de l’activité de l’aconitase (0.33±0.03 vs 0.17±0.02 
μmoles/min/mg mitochondrie), de l’expression de l’ATP synthase sous unité β (H 0.73±0.02 vs. Ctrl 
0.59±0.02 unité relative, +25%; p<0.05) et de l’expression de MnSOD (H 0.89±0.02 vs. Ctrl 
0.74±0.03 unité relative, +20%; p<0.05) (superoxide dismutase mitochondriale, important 
antioxidant), tandis que l’expression de Prx3 est significativement réduite (H 1.1±0.07 vs. Ctrl 
0.85±0.01 unité relative, -24%; p<0.05). À 4 semaines, les mâles H (vs Ctrl) présentent une 
augmentation significative de l’expression de Prx3 (H 0.72±0.03 vs. Ctrl 0.56±0.04 unité relative, 
+31%; p<0.05) et les femelles présentent une augmentation significative de l’expression d’UCP2 (H 
1.22±0.05 vs. Ctrl 1.03±0.04 unité relative, +18%; p<0.05) et de l’expression de MnSOD (H 
1.36±0.01 vs. 1.19±0.06 unité relative, +14%; p<0.05). 
Conclusions: Une exposition néonatale à l’O2 chez le rat adulte mène à des indices de dysfonction 
mitochondriale dans les reins adultes, associée à une augmentation dans la production d’espèces 
réactives de l’oxygène, suggérant que ces modifications mitochondriales  pourraient jouer un rôle 
dans l’hypertension artérielle et d’un stress oxydant, et par conséquent, être un facteur possible 
dans la progression vers des maladies cardiovasculaires.  
 
 
Mots-clés: Mitochondries, Reins, Hypertension, Oxygène, Stress Oxydant, Programmation 
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ABSTRACT 
EVALUATION OF MITOCHONDRIAL FUNCTION IN A MODEL OF DEVELOPMENTAL 
PROGRAMMING OF HYPERTENSION ASSOCIATED WITH TRANSIENT NEONATAL OXYGEN 
EXPOSURE 
Introduction: Rats exposed to oxygen (O2) as newborns suffer complications in adulthood, 
including: arterial hypertension, vascular dysfunction, nephropenia and indices of oxidative stress. 
Although the rats are born at term, their organ development is equivalent to that of a preterm 
fetus, allowing organs of interest such as the kidney to be compared to premature infants. Given 
that impaired nephrogenesis or reduced nephron numbers has been shown to promote the 
development of hypertension and mitochondrial dysfunction is associated with increased 
oxidative stress, we hypothesised that exposure to high oxygen concentrations in the neonatal 
period would significantly impact the expression and activity of key proteins involved in renal 
mitochondrial function and lead to an excessive production of reactive oxygen species by the 
mitochondria.  
Methods: Sprague-Dawley rat pups were exposed to 80% O2 (Hyperoxic (H) group; O2 exposed) or 
21% O2 (Control (Ctrl) group)  from day 3 to day 10 of life. At 4 and 16 weeks of age, kidneys were 
rapidly excised and the mitochondria isolated following a standard protocol; with a buffer 
containing 0.32 M sucrose and differential centrifugations. Expression of mitochondrial proteins 
was assessed by Western blot, whereas the release of hydrogen peroxide (H202), activities of key 
citric acid cycle enzymes and mitochondrial swelling were assessed by spectrophotometry. Results 
are expressed as the means ± SE. Both male and female offspring were studied. 
Results: In male H rats at 16 weeks of age (n=6), citrate synthase activity (internal standard and 
measure of relative mitochondrial abundance) was significantly increased (12.4 ± 8.4 vs 4.1 ± 0.5 
μmole/mL/min), whereas aconitase activity (sensitive to ROS) was significantly decreased (0.11 ± 
0.05 vs 0.20 ± 0.04 μmoles/min/mg mitochondria) and H202 release was significantly increased (7.0 
± 1.3 vs 5.4 ± 0.8 ρmoles/mg mitochondrial protein) compared to the controls (Ctrl, n=6 males and 
4 females). The H group (vs Ctrl) also demonstrated a reduction in the expression of 
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peroxiredoxin-3 (Prx3) (H 0.61±0.06 vs. Ctrl 0.78±0.02 relative units, -23%; p<0.05), a protein 
involved in the elimination of H202 and in the expression of cytochrome C oxidase (Complex IV) (H 
1.02±0.04 vs. Ctrl 1.20±0.02 relative units, -15%; p<0.05), a protein in the mitochondrial 
respiratory chain, whereas the expression of uncoupling protein-2 (UCP2), a protein involved in 
dissipating the proton gradient, was significantly increased (H 1.05±0.02 vs. Ctrl 0.90±0.03 relative 
units, +17%; p<0.05). Female H rats (n=6) (vs Ctrl, n=6) at 16 weeks of age demonstrated a 
significant increase in aconitase activity (0.33±0.03 vs 0.17±0.02 μmoles/min/mg mitochondria), in 
the expression of ATP synthase β subunit (H 0.73±0.02 vs. Ctrl 0.59±0.02 relative units, +25%; 
p<0.05) (involved in ATP production) and in the expression of MnSOD (H 0.89±0.02 vs. Ctrl 
0.74±0.03 relative units, +20%; p<0.05) (mitochondrial antioxidant involved in scavenging 
superoxide), whereas Prx3 expression was significantly reduced (H 1.1±0.07 vs. Ctrl 0.85±0.01 
relative units, -24%; p<0.05 ).  In male H rats (vs Ctrl) at 4 weeks of age, the expression of Prx3 was 
significantly increased (H 0.72±0.03 vs. Ctrl 0.56±0.04 relative units, +31%; p<0.05). Female H rats 
(vs Ctrl) at 4 weeks of age demonstrated a significant increase in the expression of UCP2 (H 
1.22±0.05 vs. Ctrl 1.03±0.04 relative units, +18%; p<0.05) and in the expression of MnSOD (H 
1.36±0.01 vs. 1.19±0.06 relative units, +14%; p<0.05). 
Conclusion: The findings of this study demonstrate that transient oxygen exposure in the neonatal 
rat modifies protein expression, enzymatic activity and leads to indices of mitochondrial 
dysfunction (increase in ROS) in the adult kidney; these adverse changes in the mitochondria were 
more pronounced in adult males than in females. Overall, these findings,  suggest that impaired 
mitochondrial function is associated with and could play a role in the development of arterial 
hypertension, oxidative stress and cardiovascular disease associated with transient neonatal 
hyperoxic stress. 
 
Keywords: Mitochondria, Hypertension, Kidneys, Developmental Programming, Oxygen, ROS 
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1.0 INTRODUCTION 
It is now well recognized that low birth weight can significantly impact adult health and disease, 
particularly the cardiovascular system1-3; this concept is termed ‘developmental programming’. 
Low birth weight (classically defined as <2500g) can result from intrauterine growth restriction 
and/or premature birth. Human and experimental studies have shown that developmental 
programming of hypertension is associated with vascular dysfunction, vascular oxidative stress 
and impaired nephrogenesis. The exact mechanisms underlying programming of elevated blood 
pressure are only partly understood. Among the many factors implicated in adverse perinatal 
conditions and developmental programming of hypertension, oxidative stress seems an important 
common denominator. Prematurely born infants are at high risk of sustaining oxidative stress 
because of their immature antioxidant defenses and the exposure to prooxidant conditions 
(increase in arterial pO2 upon birth, exposure to infection, inflammation and supplemental 
oxygen). The current master’s studies will examine in a rodent model of developmental 
programming of hypertension associated with neonatal exposure to hyperoxic stress (as a model 
of prematurity associated prooxidant conditions), whether renal mitochondria function is 
impaired, and contribute to enhance oxidative stress later in life.  
 
Clinical relevance of current studies:  
1.1 Prematurity 
Prematurity is defined as the birth of a child prior to 37 completed weeks of gestational age4. 
Infants born before 32 weeks are defined as ‘very preterm’ and those born before 28 weeks as 
‘extremely preterm’. Prematurity affects about 8% of births in Canada5 and almost 13% in the 
United States6.  
There are many conditions associated with preterm birth, such as spontaneous preterm labour, 
premature pre-labour rupture of membranes (PPROM), infection (both overt and subclinical such 
as bacterial vaginosis and periodontal disease), multiple gestations, pre-eclampsia, intrauterine 
growth restriction, antepartum haemorrhage, cervical insufficiency, and uterine malformations6.  
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The incidence of preterm birth has increased over recent decades8. Preterm birth is a global 
phenomenon with varying prevalence according to differences in health care throughout the 
world. For example, the prevalence of preterm births exceeds 12% in the United States6 with an 
even higher prevalence amongst certain ethnic backgrounds (highest risk in black and Indigenous 
women, lowest risk in Hispanic and east Asian women11). These high rates are comparable to 
those found in some third world countries and significantly exceed rates in Europe and the 
Scandinavian countries9. The preterm birth rate remained stable in Canada between 2004 and 
2008, fluctuating between 7.7% and 8.2%, with an average of 7.9%5. 
Preterm birth is the leading cause of perinatal morbidity and mortality9. The most prominent 
short-term complications of preterm birth include brain injury, bronchopulmonary dysplasia and 
retinopathy of prematurity9.  Technological advances in prenatal care have led to an increase in 
survival rates into young adulthood of these prematurely born infants9, causing long term 
consequences of preterm birth to become more clinically evident. In a national cohort examined 
by Moster et al. which included children who were born at a wide range of gestational ages and 
who were followed until adulthood, the risk of severe medical disabilities increased sharply with 
decreasing gestational age at birth12. Impact of preterm birth on neurodevelopment has been 
extensively studied12, 13; however, long term impact on other organs/systems is much less known.  
 
1.2 Long-term consequences of preterm birth 
As mentioned, the concept that many adult conditions or diseases can have their origins traced 
back to fetal and early postnatal life has been termed ‘developmental programming’15. There are 
multiple insults or factors that can affect a developing fetus leading to the programming of adult 
diseases such as nutrition, oxidative stress and inflammation, glucocorticoids, fetal hypoxia, and 
epigenetic changes16. Revolutionary studies spanning several decades, with David Barker as the 
pioneering figure, demonstrated that low birth weight (assimilated to impaired fetal growth in 
most studies) is associated with raised blood pressure17, hypertension17 and cardiovascular 
mortality later in life in both males and females18. Not only is cardiovascular health affected in the 
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long-term but also other markers of metabolic syndrome, including: type 2 diabetes or insulin 
resistance19-21, dyslipidemia22, 23 and obesity21, 24, as well as chronic kidney diseases25. The ‘fetal or 
developmental origins/programming of disease’ concept is now well accepted but the mechanisms 
of programming remain poorly understood26, 27. Developmental studies taking into account 
gestational age, and therefore prematurity, into their analyses are fewer and examine younger 
populations of individuals. 
Recently, a number of studies have shown an increased risk of developing cardiovascular disease 
in children and adults born preterm28-31. Teenagers and young adults born preterm showed a 5 to 
6 mmHg greater mean systolic blood pressure (SBP) compared to those born at term, even after 
taking (restricted) fetal growth into account32. Similarly, Vohr et al.33 demonstrated higher systolic 
blood pressure and higher rates of systolic prehypertension and hypertension in former preterm 
16-year-old adolescents compared to term controls. A study by Skilton et al., demonstrated that 
maximum aortic thickness, measured as maximum aortic intima-media thickness (IMT) was 
significantly higher in babies with intrauterine growth restriction (810 μm [SD 113]) than in those 
without (743 μm [76])34.  An increased aortic thickness increases the probability of developing 
atherosclerosis and consequently cardiovascular risk. This follows the trend that birth weight is 
highly important with regards to the onset of diseases in adulthood. In addition, a study by Jiang et 
al. found that 9 year-old children (both male and female) who had weighed less at birth (after 
adjusting for current body size and maternal pre-pregnancy size) had significantly smaller total 
coronary artery diameter, aortic root diameter and left ventricular outflow diameter35. A smaller 
coronary artery diameter has been linked to a higher prevalence of atherosclerotic lesions36, and a 
poorer outcome after cardiac interventions or invasive procedures such as coronary bypass 
surgery or angioplasty37. An important element in the development of hypertension and 
cardiovascular disease is endothelial dysfunction which precedes the disease outcome and 
therefore may be an important target for prevention strategies38. In 17-28 years old prematurely 
born adults (1000g), endothelial function (evaluated by brachial artery flow mediated 
vasodilation) is attenuated and correlated with gestational age at birth39. These cardiovascular 
system dysfunctions may also correspond to the observed increased risk of cardiovascular events.  
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Renal development and function has also been shown to be impaired as a result of preterm birth25, 
40, 41. In the human fetus, nephrogenesis reaches completion at approximately 34-36 weeks of 
gestation with more than 60% of nephrons being formed during the last trimester9, 42. In infants 
born prior to 36 weeks of gestation, nephrogenesis is still ongoing making them highly susceptible 
to a reduced nephron number, be it through intrauterine stress or prenatal or postnatal 
perturbations43. Lackland et al.44 reported an inverse relationship between birth weight and renal 
failure from all causes of ESRD in Caucasians and African Americans in both males and females in 
the south-eastern United States. In addition a Norwegian cohort comprised of 526 subjects 
examined with 38 years of follow-up by Vikse et al45 revealed that low birth weight conferred a 
70% increased risk for end-stage renal disease (ESRD) in those born with a birth weight 10th 
percentile compared within the 10th to 90th percentiles. Similarly, the outcome was observed in 
both men and women and persisted after adjustments for other birth-related variables. Brenner et 
al.46 proposed a mechanism for this observed phenomenon, suggesting that impaired or retarded 
fetal growth leads to a reduced number of nephrons, which in turn leads to increased hydrostatic 
pressure in the glomerular capillaries, glomerular hyperfiltration, and the development of 
glomerular sclerosis. This sclerosis can lead to further loss of nephrons as the glomerular 
hypertension and hyperfiltration worsen46, ultimately contributing to elevation and maintenance 
of high blood pressure. 
 
1.3 Reactive Oxygen Species 
Reactive oxygen species (ROS) is a term used to describe a variety of molecules and free radicals 
(chemical species with one unpaired electron) derived from molecular oxygen. The superoxide 
anion (O2-); the product of a one-electron reduction of oxygen is central to ROS chemistry as it is 
the precursor of most ROS and a mediator in oxidative chain ractions47, 48. Dismutation of O2 
(either spontaneously or through a reaction catalyzed by superoxide dismutases) produces 
hydrogen peroxide (H202), which in turn may be fully reduced to water or partially reduced to 
hydroxyl radical (OH-), one of the strongest oxidants in nature49. The formation of OH- is catalyzed 
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by reduced transition metals, which can be reduced again by O2-, driving this process. ‘Oxidative 
stress’ is an expression used to describe an imbalance between pro-oxidants (excessive formation 
of ROS and/or reactive nitrogen species) and limited antioxidant defences as a result of various 
deleterious processes50 or immature in development. 
Reactive oxygen species are one of the major contributors of oxidative stress and are also essential 
signalling molecules required by the cell for normal cellular function. However, when there is an 
imbalance between ROS production and antioxidant levels, ROS act as oxidizing agents that can 
potentially trigger cell death via the induction of apoptosis or necrosis51. Excessive ROS production 
is thought to underpin many pathologies associated with neurological degenerative diseases (e.g. 
Alzheimer & Parkinson diseases), obesity, diabetes (types 1 and 2), metabolic syndrome, 
cardiovascular disease and ageing52. 
ROS include free radicals such as superoxide anion (O2-), hydroxyl radical (OH), lipid radicals (ROO-
) and nitric oxide (NO). Other reactive oxygen species, hydrogen peroxide (H202), peroxynitrite 
(ONOO-) and hypochlorous acid (HOCl), although they are not free radicals, have oxidizing effects 
that contribute to oxidative stress53. ROS has been implicated in cell damage, necrosis and cell 
apoptosis due to its direct oxidizing effects on macromolecules such as lipids, proteins and DNA48. 
 
1.3.1 INTRACELLULAR SOURCES OF REACTIVE OXYGEN SPECIES 
 
1.3.1.1  NADH/NADPH oxidase system  
NADH/NADPH oxidases are membrane-associated enzymes that catalyse the 1-electron reduction 
of oxygen using NADH or NADPH as the electron donor (Figure 1). NADH/NADPH oxidases, initially 
described in neutrophils, are the most important oxidases in vascular tissue and in cardiac cells54, 
are important sources of endovascular ROS and are also integral to the generation of ROS in 
phagocytic cells48, 55. 
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NADH/NADPH activity is regulated by a number of factors known to be involved in the 
pathogenesis of cardiovascular disease including cytokines, hormones, local metabolic changes 
and haemodynamic forces56. Shear stress (of vascular wall) can have variable effects on  NADPH 
oxidase, be it a transient elevation or a sustained increase48. NADH/NADPH-dependent oxidase 
activity and consequently NADH/NADPH driven O2- production are also increased in vascular 
smooth muscle cells by stimulation with angiotensin II48. 
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Figure 1: Structure of NAD(P)H oxidase (Reprinted from Rabelo et al.57).  NADPH oxidase consists 
of the membrane-bound gp91phox and p22phox, the cytosolic proteins p47 and p67, and a low 
molecular-weight G protein (rac). 
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1.3.1.2  Xanthine oxido-reductase system  
Xanthine oxido-reductase exists in two interconvertible forms, either as xanthine dehydrogenase 
or xanthine oxidase58. The first form reduces NAD+ whereas the latter produces superoxide anion 
and hydrogen peroxide via a reaction with O2
48, 59. The dual role means that it is an important 
regulator of cellular redox state. Xanthine oxidase generates ROS via purine metabolism pathway 
and is involved in causing endothelial dysfunction in patients with coronary disease and contractile 
dysfunction in heart failure48. Studies have shown that xanthine oxidase expression and activity 
are increased in cardiomyocytes isolated from failing hearts60-63. 
 
1.3.1.3  Nitric oxide synthase uncoupling  
Recent studies have demonstrated the crucial role of endothelial NOS (eNOS) as a ROS producing 
enzyme; resulting in vascular endothelial dysfunction48, 64. When tetrahydrobiopterin (BH4) is 
limited, electron transfer becomes uncoupled to L-arginine oxidation, leading to the dissociation of 
the ferrous dioxygen complex and superoxide is produced64. Endothelial NOS can produce both NO 
via its oxygenase function and superoxide through its reductase function (dependent on NADPH)48. 
The product of the reaction between NO and O2- can oxidize BH4 which may lead to further eNOS 
uncoupling. Imbalance between endothelial NO and ROS production is one of the major 
contributors of endothelial dysfunction which plays an important part in the development of 
atherosclerosis and cardiovascular disease48. 
 
1.3.1.4  Mitochondrial electron transport chain  
The major source of ROS is considered to be the mitochondrial electron transport chain in the 
inner mitochondrial membrane, with respiratory complexes I and III being the major sites of 
superoxide formation in the electron transport chain65 (Figure 2). 
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In the vasculature and the kidneys, ROS derive mainly from the mitochondrial electron transport 
chain, NAD(P)H oxidases and uncoupled nitric oxide synthase (NOS)67. For the current research, we 
will focus on the impact of mitochondria (dys)function. The roles of NAD(P)H oxidase and of 
(uncoupled) NOS-derived ROS in vascular dysfunction after neonatal hyperoxic stress were 
examined in a series of recent studies from the laboratory. 
1.4 Oxidative Stress 
Oxidative stress is mainly caused by an imbalance between the activity of endogenous pro-
oxidative enzymes (such as NADPH oxidase, xanthine oxidase, uncoupled NO synthase or the 
mitochondrial respiratory chain) and antioxidant enzymes (such as superoxide dismutase, 
glutathione peroxidase, heme oxygenase, thioredoxin peroxidase/peroxiredoxin, catalase and 
paraoxonase)68. 
Under oxidative stress, excessive superoxide also releases free iron from iron-containing 
molecules, which further generate highly reactive hydroxyl radicals (OH) by reacting with 
hydrogen peroxide via the Fenton reaction69. ROS can also induce the opening of the mitochondria 
membrane permeability transition pore (PTP) and cause a release in cytochrome c and other 
factors that can lead to apoptosis-mediated cell death48. 
Under physiological conditions, cells increase activities of antioxidant enzymes and other 
antioxidant defences in order to counter-act the occurrence of oxidative stress. These antioxidants 
include Copper/Zinc superoxide dismutase (Cu/Zn SOD), manganese-dependent superoxide 
dismutase (MnSOD), glutathione peroxidase, glutathione reductase and catalase (CAT). MnSOD 
and Cu/Zn SOD convert O2- to hydrogen peroxide, which is then transformed to water by 
glutathione peroxidase, catalase or peroxiredoxin48, 70. The thioredoxin system is composed of 
several proteins including peroxiredoxin, that are important in redox homeostasis due to their ROS 
scavenging ability71. Other antioxidant defences include radical scavengers such as vitamin E, beta 
carotene and vitamin C48. (Figure 3) 
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al. found that initiating resuscitation with 30% versus 90% oxygen for infants 28 weeks’ gestation 
or less significantly reduced the risk of developing bronchopulmonary dysplasia74, 76. Even brief 
exposure to high levels of oxygen induces oxidative stress, and the subsequent production of 
oxygen free radicals can be extremely dangerous, particularly for preterm infants who lack 
adequate protection from indigenous antioxidants75. Since fetal life takes place in a relatively 
hypoxic environment, preterm birth results in the sudden and premature exposure to 
comparatively high levels of oxygen and oxidative stress results from the lack of protection 
(underdeveloped antioxidant system) coupled with the necessary supplemental oxygen therapy to 
treat this population. This increased risk of oxygen toxicity poses a significant threat of tissue 
damage in response to reactive oxygen species and excess free radicals75. 
The vast spectrum of disease evident in the neonatal period includes those that stem from the 
interruption of normal organogenesis in the vascular tree, pancreas, lung and kidney9. Of 
particular relevance for the current Master thesis, kidney development (nephrogenesis) begins at 
approximately day 30 of gestation, with the majority of nephrons being formed between week 20 
until 34 to 36 weeks of gestation14. Given that nephrogenesis is still ongoing prior to 34 weeks of 
gestation, it is very likely that neonates born at less than 34 weeks of gestation will experience 
alterations in the structural development of the kidney14. In addition, the extrauterine 
environment is suboptimal for organogenesis due to the exposure to a number of insults, including 
high oxygen concentrations14. Oxidative stress has emerged as a likely promoter of several 
pregnancy-related disorders, such as spontaneous abortions, embryopathies, preeclampsia, fetal 
growth restriction, preterm labor and low birth weight77. 
Saugstad et al.78 described the implications of oxidative stress in a number of conditions affecting 
premature infants, including: bronchopulmonary dysplasia (BPD) or chronic lung disease (CLD), 
retinopathy of prematurity (ROP), necrotizing enterocolitis (NEC) and patent ductus arteriosus. A 
number of studies indicate that the development of CLD is related to oxidative stress detected by 
the augmentation of peroxidation products in the very first days of life79, 80. Retinopathy of 
prematurity (ROP) is thought to occur through the frequent hyperoxygenation of the retina and 
subsequent oxidative damage due to the limited antioxidant defense of the retina in the preterm 
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infant81. A study by Papp et al. discovered that the ratio of oxidized to reduced glutathione more 
than doubled in patients with ROP compared with controls, and may be used as a method of 
identifying infants at risk of developing ROP82. 
Newborn infants possess an underdeveloped antioxidative capacity, and when exposed to a 
greater percent oxygen concentration relative to the intrauterine milieu83, they are at a 
significantly higher risk of oxidative stress; a fact supported by many studies in both human and 
animal models84-86. A study by Lee et al.87 showed that smaller preterm infants (SPT) had 
significantly lower levels of GSH and NADPH ratio compared to larger preterm infants (LPT). GSH 
and the NADPH ratio are believed to be important indices of the cellular redox state88 and when 
impaired can lead to ROS generation48. It was further demonstrated that preterms had increased 
glucose-6-phosphate dehydrogenase (G6PD) activity compared to full term appropriate-for-age 
infants, suggesting a compensatory mechanism to combat an adverse environment87, as patients 
with G6PD deficiency often have lower antioxidant capacities89. Georgeson et al.90 reported 
significantly higher catalase (CAT), glutathion peroxidase (GPX), and Cu/Zn-SOD activity in healthy 
neonates, in the full-term normal spontaneous vaginal delivery (FT-NSVD) category compared to 
preterm normal spontaneous vaginal delivery (PT-NSVD)90. Of further importance for the current 
work is the role of oxidative stress and free radicals in renal injury. Studies by Vento et al.91 and 
Perrone et al.92, showed elevated concentrations of N-acetyl-glucosaminidase in the days 
following birth in preterm babies (a reliable marker for detecting renal tubular damage after 
neonatal anoxia). This increase in N-acetyl-glucosaminidase concentration demonstrates the 
correlation between indices of oxidative stress and kidney damage92. These results clearly 
demonstrate that preterm neonates possess an impaired antioxidant capacity relative to their 
term counterparts which may compromise their ability to deal with oxidative stress, predisposing 
them to the diseases discussed above.  
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1.6 Oxidative Stress and its role in programming 
Oxidative stress both during fetal and neonatal life is considered a key element in programming of 
long-term cardiovascular consequences93-95 (see Figure 4). Regarding the kidney, Yzydorczyk et 
al.83 explored the relationship between neonatal O2 exposure and long-term renal damage. A 
significant reduction in nephron number was observed in both male and female rats exposed to 
80% oxygen (hyperoxic group) from day 3 to day 10 of life compared to the control (room air) and 
examined at 25-35 weeks of age (which corresponds to an adult in humans). Nephrogenesis in rats 
proceeds until 5 to 8 days postnatally83 compared to 32-36 weeks in humans96, allowing the kidney 
to be compared to that of a preterm infant. Since nephron number is decreased in adult patients 
with primary hypertension97, and reduced nephron endowment is a function of impaired renal 
growth, the kidney is an important organ to explore in the development (programming) of 
hypertension. Furthermore, oxygen tension has been shown to possess a regulatory role in 
nephrogenesis through hypoxia-inducible factor (HIF)98 which regulates expression of genes 
involved in angiogenesis and rat organogenesis appears to be enhanced in low (1-3%) O2 
concentration compared to the standard (21%) O2 concentration
83. All of these factors clearly 
indicate that the kidney is adversely affected under high oxygen concentrations and since 
mitochondria are known to be the primary producers of ROS65, it is important to investigate 
possible effects of oxidative stress and programming of adult disease on mitochondria function in 
the kidney. 
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Figure 4: Representation of potential common pathways in the ‘fetal origins of adult disease’ 
theory (Reprinted from Davidge et al.99). 
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1.7 Mitochondria 
Mitochondria (shown in Figure 5) are surrounded by a double-membrane system, consisting of 
inner and outer mitochondrial membranes separated by an intermembrane space. The inner 
membrane forms numerous folds (cristae), which extend into the interior (or matrix) of the 
organelle and provide a greater surface area for the production of ATP. Each component is 
responsible for distinct functional roles, with the matrix and inner membrane accounting for the 
vast majority of mitochondrial work and ATP production100. 
Mitochondria also contain their own genome, which is separate and distinct from the nuclear 
genome of the cell. Mitochondrial DNA (mtDNA) follows maternal inheritance and is termed 
‘naked’ DNA since it lacks histone protection and has a weak repair capacity, making it more 
vulnerable to damage than nuclear DNA101. The level of oxidized bases in mtDNA is 10- to 20-fold 
higher than in nuclear DNA102. 
 
 
Figure 5: Structure of a mitochondrion (Reprinted from Cooper et al.100). 
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1.7.1 Mitochondrial Function 
Mitochondria are the primary energy-generating system in most eukaryotic cells and play a crucial 
role in energy metabolism through their involvement in ATP production by oxidative 
phosphorylation103. Apart from energy conversion, mitochondria take part in a number of other 
processes including calcium homeostasis, nucleotide precursor biosynthesis, cofactor biosynthesis, 
and apoptosis104. Given that mitochondria are involved in so many important and well-established 
functions, mitochondrial dysfunction has a multitude of effects in multicellular organisms, some of 
which remain poorly understood103. Importantly, dysfunction of the mitochondria has been linked 
to a wide range of human disorders, including, cancer, neurodegenerative diseases, Type 2 
Diabetes and hypertension 105, 106 and at a cellular level can contribute to inflammation, ageing, 
apoptosis and alterations in cellular calcium handling104. 
 
1.7.2 The Citric Acid Cycle 
The citric acid cycle is located in the mitochondrial matrix and plays a crucial role in regulating cell 
metabolism through the production of reducing equivalents in the form of nicotinamide adenine 
dinucleotide (NADH) and flavin adenine dinucleotide (FADH2)
107, 108. It is through the rate of 
delivery of these reducing equivalents to the electron transport chain, along with adenosine 
diphosphate that the citric acid cycle is able to regulate oxidative phosphorylation. This flux 
through the citric acid cycle is dependent upon the supply of acetyl units, activation of the three 
non-equilibrium reactions within the citric acid cycle and the total concentration of the citric acid 
cycle intermediates107. The cycle (dependent on oxygen) is also an important source of precursors, 
not only for the storage forms of fuels, but also for the building blocks of many other molecules 
such as amino acids, nucleotide bases, cholesterol, and porphyrin (the organic component of 
heme)109. 
The citric acid cycle includes a series of oxidation-reduction reactions that result in the oxidation of 
an acetyl group to two molecules of carbon dioxide; transforming fuel molecules into ATP via the 
electron transport chain109. The overall pathway of the citric acid cycle is shown in Figure 6. 
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110 
Figure 6: Overview of the Citric Acid Cycle (Reprinted from Berg et al.109) The citric acid cycle 
oxidizes two-carbon units, producing two molecules of CO2, one molecule of GTP, and high-energy 
electrons in the form of NADH and FADH2. A four-carbon compound (oxaloacetate) condenses 
with a two-carbon acetyl unit to yield a six-carbon tricarboxylic acid (citrate), which undergoes a 
series of decarboxylations producing succinate. Oxaloacetate is then regenerated from succinate. 
Two carbon atoms enter the cycle as an acetyl unit and two carbon atoms leave the cycle in the 
form of two molecules of carbon dioxide. Three hydride ions (six electrons) are transferred to 
three molecules of nicotinamide adenine dinucleotide (NAD+), whereas one pair of hydrogen 
atoms (two electrons) is transferred to one molecule of flavin adenine dinucleotide (FAD). The 
function of the citric acid cycle is the harvesting of high-energy electrons from carbon fuels109. CS, 
citrate synthase; ACON, aconitase; ICD, isocitrate dehydrogenase; KGD, α-ketoglutarate 
dehydrogenase; SCS, succinyl-CoA synthetase; SD, succinate dehydrogenase; FUM, fumarase; MD, 
malate dehydrogrenase. 
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Aconitase (mitochondrial, m-aconitase) is localized in the mitochondrial matrix. It catalyzes 
conversion of citrate to isocitrate as part of the citric acid cycle. The enzyme is inactivated upon 
oxidation of its iron-sulfur cluster by superoxide. Upon inactivation, isolated aconitase induces 
production of hydroxyl radical, most likely mediated by the release of Fe2+. 111 
Experimental studies have shown that specific enzymes of the citric acid cycle are susceptible to 
oxidation112-114. Aconitase exhibits the most significant age-associated decline in activity and is 
known to be highly susceptible to oxidative damage110. Citrate is a key intermediate in the citric 
acid cycle and in fatty acid synthesis, and increased citrate synthase activity may contribute to 
progressive renal injury115. 
 
1.7.3 Electron Transport Chain 
The respiratory chain, located in the inner mitochondrial membrane, consists of five multimeric 
protein complexes116 (Figure 8). Mitochondrial ATP production relies on the electron transport 
chain, composed of respiratory chain complexes I-IV, which transfer electrons in a stepwise 
fashion until they finally reduce oxygen to form water117. Mitochondria contain their own genome, 
13 polypeptides, all of them structural subunits of the oxidative phosphorylation complexes I, III, 
IV and V are encoded118. As explained by Mailloux et al.119, NADH: ubiquinone oxidoreductase 
(complex I) is composed of approximately 45 subunits and is the site of NADH oxidation. The flavin 
mononucleotide of complex I accepts the electrons from NADH and passes them through a series 
of eight iron-sulfur clusters to ubiquinone. Ubiquinol: cytochrome c oxidoreductase (complex III) 
has 11 subunits and contains three hemes and a Fe-S cluster center. Complex III plays a crucial role 
in funneling electrons from the ubiquinol generated by complexes I and II to cytochrome c. Upon 
binding to the Qo site of complex III, one electron from ubiquinol is ferried through the Rieske Fe-S 
cluster protein to the electron acceptor, cytochrome c. The resulting unstable semiquinone then 
donates the remaining electron to the cytochrome b hemes (cytochrome bL and bH). The electron 
in cytochrome b is then used to re-reduce ubiquinone in the Qi site to produce ubiquinol. Two 
electrons from semiquinones in the Qo are required for the reduction of ubiquinone to ubiquinol 
in the Qi site. This is referred to as the Q-cycle (Figure 7) because lone electrons remaining in 
semiquinone are reused to reduce ubiquinone back to ubiquinol. This electron cycling mechanism 
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1.7.4 Mitochondrial ATP production  
Mitochondria play a central role in energy metabolism through their significant contribution to 
adenosine triphosphate (ATP) production; this process depends on oxygen. When oxygen is 
limited, the less efficient process of anaerobic respiration metabolizes glycolytic products directly 
in the cytosol121, 122. NADH and FADH2 are energy rich molecules formed in glycolysis, fatty-acid 
oxidation and the citric acid cycle that donate electrons to the ETC, establishing an electrochemical 
gradient122. Electrons move toward compounds with more positive oxidative potentials and the 
incremental release of energy during the electron transfer is used to pump protons (H+) into the 
intramembrane space. As described in a recent review by Bratic and Trifunovic (2010)121 
complexes I, III and IV function as H+ pumps that are driven by the free energy of coupled 
oxidation reactions. During the electron transfer, protons pumped from the mitochondrial matrix 
to the intermembrane space produce a potential of around 150-180 mV121, 123. The proton gradient 
generates a chemiosmotic potential, also known as the proton motive force, which drives the ADP 
phosphorylation via the ATP synthase (F0F1-ATPase-Complex V). The rate of mitochondrial 
respiration depends on the phosphorylation potential expressed as [ATP]/[ADP][Pi] ratio across 
the inner mitochondrial membrane that is regulated by the adenine nucleotide translocase (ANT). 
In the case of increased cellular energy demand, when the phosphorylation potential is decreased 
and more ADP is available, a respiration rate is increased leading to an increased ATP synthesis. 
Tight coupling between the electron transport and the ATP synthesis and an inhibition of ATP 
synthase will therefore also inhibit the electron transport and cellular respiration. Under certain 
conditions, protons can re-enter into mitochondrial matrix without contributing to the ATP 
synthesis and the energy of proton electrochemical gradient will be released as heat. This process, 
known as proton leak or mitochondrial uncoupling could be mediated by protonophores (such as 
FCCP) and uncoupling proteins (UCPs)121. 
Mitochondrial ATP production is fuelled by the chemical energy stored within the carbon-to-
carbon bonds of various energy substrates and relies on the great oxidative power of diatomic 
oxygen (O2). After the oxidation of substrates in the citric acid cycle, the resulting electron carriers, 
NADH and FADH2, are oxidized by complexes I and II respectively. The liberated electrons/reducing 
equivalents are then transferred through the respiratory complexes III and IV via prosthetic groups 
arranged in increasing redox potential to the terminal electron acceptor, O2. This generates a 
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proton-motive force (Δp) across the mitochondrial inner membrane. This stored potential energy 
is then tapped by the F0F1-ATP synthase as protons move through it back to the matrix and drive 
ATP formation from ADP and Pi. This process is referred to as coupled respiration because the 
energy derived from the transfer of electrons to the terminal electron acceptor O2 is completely 
harnessed to drive ATP production. However, the reduction of dioxygen to water during aerobic 
respiration is accompanied by variable extents of reactive intermediate formation, because the 
two outermost electrons in molecular oxygen occupy separate orbitals. Consequently, the 
univalent reduction of O2 results in the formation of various singlet-electron-containing 
intermediates that can damage the cell119 (see Figure 8). 
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Figure 8: Mitochondrial energy metabolism (Reprinted from DiMauro et al.116).  Overview of the 
numerous tasks performed by mitochondria, including : pyruvate oxidation, the citric acid (TCA) 
cycle, metabolism of amino acids, fatty acids, and steroids, but the most important is the 
generation of adenosine triphosphate (ATP) via the electron-transport chain and the oxidative-
phosphorylation system (the ‘respiratory chain’)116. ADP, adenosine diphosphate; ANT, adenine 
nucleotide translocator; CACT, carnitine-acylcarnitine translocase; CoQ, coenzyme Q; CPT, 
carnitine palmitoyltransferase; DIC, dicarboxylate carrier; ETF, electron-transfer flavoprotein; ETF-
DH, electron-transfer dehydrogenase; FAD, flavin adenine dinucleotide; FADH2, reduced FAD; 
NADH, reduced nicotinamide adenine dinucleotide; PDHC, pyruvate dehydrogenase complex; TCA, 
tricarboxylic acid; I, complex I; II, complex II; III, complex III; IV, complex IV; V, complex V. 
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1.7.5 ROS production and handling in the mitochondria 
Approximately 90% of cellular oxygen is consumed within the mitochondria, accounting for nearly 
90% of the total ROS produced in the cell121, 124. ROS have dual roles within aerobic cells, whereby 
they may act as signalling molecules in a wide range of normal cellular processes or as oxidizing 
agents that can potentially trigger cell death119. The mitochondrial electron transport chain is the 
major ROS production site but the mitochondria are also a prime target for oxidative damage. 
With accumulating oxidative damage, such as with aging or in disease states, mitochondria 
become larger and less numerous with age, accumulating vacuoles, cristae abnormalities and 
intra-mitochondrial paracrystalline inclusions125. Mitochondrial respiratory chain enzymes 
activities decrease, as well as mitochondrial membrane potential (on which the production of ATP 
is dependent); the amount of oxidative damage to proteins and mtDNA increases, with an 
associated accumulation in the quantity of mtDNA mutations124, 126. Age-associated decline in the 
mitochondrial respiratory chain capacity has also been reported in various tissues121, including the 
kidney127. 
 
Approximately 1-2% of the O2 consumed in the mitochondria is reduced (univalently) to 
superoxide (O2-), the main molecule of ROS signalling and damage
102, 119. Superoxide is then 
usually converted into H202 by the manganese-superoxide dismutase or copper/zinc-superoxide 
dismutase, found in the mitochondrial matrix and in the intermembrane space, respectively
128. The 
high amount of O2 and the low concentration of superoxide, makes superoxide formation a very 
energetically favorable process102, 129. Superoxide can also react with nitric oxide radical (NO) to 
generate peroxynitrite (ONOO), a lipid soluble and highly toxic reactive nitrogen species. Of 
greater importance, superoxide production by the respiratory chain can increase significantly 
when the mitochondrial membrane potential is high (e.g. when ATP production is low)130, 131. 
Unlike superoxide, H202 is more stable and is able to oxidize low-molecular weight thiolating 
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agents such as glutathione (GSH). This stability allows H202 to play a key role as a mitochondrial 
signalling molecule. It is when H202 is produced in an uncontrolled fashion that it can damage the 
cell by generating hydroxyl radical through Fenton or Haber-Weiss reactions132. 
 
 
Figure 9: Overview of mitochondrial ROS production (Reprinted from Murphy133). ROS production 
by mitochondria can impair their ability to synthesize ATP and to carry out normal cellular 
functions, including the citric acid cycle, fatty acid oxidation, the urea cycle, amino acid 
metabolism, heme synthesis and FeS centre assembly. Mitochondrial oxidative damage can also 
increase the tendency of mitochondria to release proteins such as cytochrome c (cyt c) to the 
cytosol via the mitochondrial outer membrane permeabilization, thereby activating the cell’s 
apoptotic machinery. In addition, mitochondrial ROS can affect redox signalling and lead to the 
induction of the mitochondrial permeability transition pore (PTP), rendering the inner membrane 
permeable to small solutes in situations such as ischemia/reperfusion133. 
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1.7.6 Antioxidant Defense Systems 
The balance between oxidants and antioxidants is commonly referred to as the ‘redox state’48. 
Antioxidant defense is comprised of a large set of enzymes and low-molecular weight compounds 
that sequester the excess ROS molecules generated by aerobic respiration. Cells engage in a 
complex array of short and long term preventative measures such as the mild uncoupling of the 
oxidative phosphorylation system in the short term and possible upregulation of antioxidant 
enzyme expression in the long term. Some antioxidative systems can be energetically costly 
because they are reliant on both ATP and NADPH119. 
The peroxiredoxin (Prx) and GSH/glutaredoxin (Grx)/glutathione peroxidase (GPx) systems are the 
most efficient at eliminating H202 in the mitochondria and cytosol because of their low Km values 
and abundance134-136. The presence of catalase in the mitochondria is also strongly debated 
because it seems to be localized primarily in peroxisomes and to a lesser extent the cytosol. For 
example, Kirkinezos et al.137, describe mitochondria as being catalase free, whereas Radi et al.138, 
demonstrate the presence of catalase in rat hearts. The antioxidative defense system is 
rejuvenated by the reductive power of NADPH (requires energy)119. They require ATP to synthesize 
small-molecule antioxidants and molecules for the sequestration of ROS and ROS by-products. The 
reactivation of H202-scavenging system requires the reductive power of NADPH (requires energy). 
The second layer of ROS defenses is formed by enzymes dealing with the primary ROS generated 
in mitochondria, superoxide radical and hydrogen peroxide. Superoxide is a substrate for 
mitochondrial manganese-containing superoxide dismutase (MnSOD, also known as SOD2). This 
enzyme is localized exclusively to the mitochondrial matrix, and its only function is to facilitate 
dismutation of superoxide radical to H202, thereby protecting mitochondrial iron-sulfur cluster 
containing enzymes from superoxide attack111. MnSOD does not require any cofactors so the 
efficiency of this system is determined solely by the amount of enzyme present.  
Catalase is an antioxidant enzyme (ubiquitously expressed by aerobic cells containing the 
cytochrome system and is localized to the peroxisome, the nucleus, or mitochondria) that converts 
H202 into O2 and H20
137. Two isoforms of peroxiredoxins (Prx3 and Prx5) are found in mammalian 
mitochondria. Prx3 (or SP-22) is ubiquitously present in various rat tissues, including the kidney139, 
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whereas Prx5 is mainly expressed in bovine tissues, with the highest level found in testis111. 
Importantly, Prx3 gene expression is known to be induced by oxidative stress111. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Selected pathway of ROS formation and neutralization 
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1.7.7 Mitochondria and Uncoupling Proteins 
Mild uncoupling of mitochondrial oxidative phosphorylation is effectively short circuiting the 
OXPHOS system due to leak of protons from the intermembrane space to the matrix, which means 
that the protons bypass ATP synthase and cause a decrease in the mitochondrial inner membrane 
potential119. A strong correlation exists between mitochondrial membrane potential and ROS 
production; small increases in the membrane potential induce ROS formation whereas slight 
decreases can substantially diminish the production of these reactive intermediates. Although the 
mechanisms responsible for the mitochondrial proton leak are still debated140-144, the proteins 
thought to be involved include adenine nucleotide translocase (ANT) and the uncoupling proteins, 
UCPs 1-3. ROS and ROS derivatives (specifically superoxide and 4-hydroxy-2-nonenal) have been 
described as activators of UCPs 1-3. Negative feedback mechanism has been suggested in which 
increased ROS induce uncoupling to decrease the formation of these toxic species. It is generally 
thought that the two major sites of mitochondrial ROS production are complexes I and III of the 
respiratory chain119.  
UCPs are mitochondrial transporters present in the inner mitochondrial membrane and are found 
in all mammals145. Uncoupling proteins function as proton channels to allow proton leakage back 
across the inner mitochondrial membrane without creating ATP. It has been shown that O2- can 
activate UCP2146, possibly as a protective mechanism against excessive mitochondrial ROS 
formation52. 
High proton motive force comes with an additional cost, the production of ROS. Because ROS 
production is highly dependent on the proton motive force, proton leak might help to limit the 
oxidative damage. There are presently 3 identified isoforms of UCPs (UCP1, UCP2, UCP3). UCP2 
and UCP3 are recently identified UCP1 homologues but their function in normal cellular physiology 
is still unclear145, 147. UCP2 and UCP3 proteins might be involved in the proton conductance only 
upon activation with certain activators (such as ubiquinone, superoxide, reactive alkenals and 
other alkenal analogues)121. 
ANT and UCPs 1-3 contribute to inducible proton leak. However, only UCPs 2 and 3 have been 
found to catalyze a proton leak that decreases ROS emission from mitochondria. UCP2 is widely 
expressed in a number of cells and tissues including the spleen, thymus, macrophages, 
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hypothalamus, pancreatic β-cells, stomach and the kidney148. UCP3 is expressed almost exclusively 
in skeletal muscle and brown adipose tissue and to a lesser extent in the heart148. In several 
studies Brand and colleagues149, 150 provided empirical evidence that superoxide and derivatives of 
ROS, namely 4-HNE, activated proton leak through UCPs 1-3. In this mechanism, the 
overproduction of ROS by the respiratory chain activates proton leak through the UCPs, thereby 
creating a negative feedback loop that regulates ROS formation by the mitochondria119. 
 
1.7.8 Mitochondrial Permeability Transition Pore 
Apart from energy conversion, mitochondria take part in a number of other processes including 
calcium homeostasis and apoptosis151. It is well documented that an increased permeability of the 
mitochondrial membranes is a key event in controlling apoptotic pathways, with the permeability 
transition pore (PTP) thought to play a major role152-156. Prolonged opening of the PTP, a 
nonspecific high-conductance proteinaceous channel of the inner membrane, leads to collapse of 
the membrane potential, mitochondrial matrix swelling, rupture of the outer mitochondrial 
membrane and release of cytochrome C 157, 158, which can ultimately lead to energy failure of the 
cell. 
 
1.8 Hyperoxia exposure and mitochondria 
A study by Clerch et al.159, found that neonatal rats exposed to  95% O2 (hyperoxia) for 48h 
exhibited a fall in lung activity of MnSOD. This suggests that the increased production of 
superoxide during hyperoxia results in the observed decrease in MnSOD activity which worsens 
the effect of the enhanced formation of superoxide and thereby contributes in a major way to the 
loss of mitochondrial function during hyperoxia159. Further studies have shown that oxidative 
damage to mitochondrial enzymes plays a significant role in oxygen toxicity. Schoonen et al.160, 
found that exposure of Chinese hamster ovary cells to hyperoxia resulted in the inactivation of 
three key mitochondrial enzymes (NADH dehydrogenase, succinate dehydrogenase, and α-
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ketoglutarate), a 2.5-fold decrease in cellular ATP, and cell death159, 160. Fischer et al.161 found 
reduced oxidative metabolism and a fall in ATP concentration in pulmonary macrophages 
following a 72-hour oxygen exposure ( 95% O2). Campian et al.
27 reported that hyperoxia tolerant 
HeLa-80 cells, as compared to wild-type HeLa-20 cells generate substantially less ROS through 
modification of cytochrome C oxidase activity and a tighter coupling of the electron transport 
chain (ETC). This was assessed by the oxidation of three fluorescent probes, the hyperoxia-
mediated inactivation of aconitase, and the accumulation of mitochondrial protein carbonyls 
under hyperoxic conditions. Li et al.162 demonstrated that the absence of MnSOD rapidly leads to 
impairment of mitochondrial function in several organs, with the heart suffering the most 
pronounced consequences, followed by the liver and the brain. Impaired fatty acid metabolism 
was also discovered through accumulation of lipid in the liver and skeletal muscle, metabolic 
acidosis and ketosis. Interestingly, no evidence of mtDNA deletions or of structural damage to the 
mitochondria were found162. Schriner et al.163 demonstrate that catalase over expression increases 
lifespan in the mouse. Furthermore, several studies164-166 have shown decreased levels of SOD, GPx 
and catalase in newborns and small for gestational age infants exposed to various toxins (alcohol, 
tobacco, etc.) in utero. In addition, Yarian et al.110 report that among the citric acid cycle enzymes, 
aconitase exhibits the most significant age-associated decline in activity, while NADPH :NADP+ 
ratio also declined with age (important for redox balance) in mitochondria isolated from rat 
kidneys. Maintaining redox homeostasis by regulation of antioxidant defense systems or ROS 
production is therefore one of the key mechanisms for tissues to adapt to hyperoxia-induced 
oxidative stress167. An altered neonatal environment could have lasting effects on antioxidant 
enzymes and result in the observed disease phenotype. Currently not much is known about the 
precise mechanisms involved, making it especially important to determine the long-term effects. 
 
1.9 Hypothesis, Aims and Study Design 
 
1.9.1  Hypothesis 
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It was hypothesised that a transient neonatal hyperoxic stress would lead to chronic alterations in 
cellular oxidant/antioxidant coupling through the modulation of the expression of key proteins 
involved in mitochondrial function, enzymatic activity of key citric acid cycle enzymes and an 
excessive production of ROS. 
 
1.9.2  Aims 
To evaluate the expression and function of key proteins and enzymes participating in 
mitochondrial function and antioxidant capacity in the kidney of adult rats exposed to high oxygen 
as newborns; at 4 and 16 weeks of age. 
 
1.9.3  Study Design 
To address the aims of this study, Sprague-Dawley rat pups were exposed to 80% O2 from day 3 to 
day 10 of life and studied at 4 and 16 weeks. Although the rats are born at term, their organ 
development is equivalent to that of a human preterm fetus, allowing organs of interest such as 
the kidney to be compared to premature infants99. Therefore the rat is an ideal model to examine 
the effects of neonatal hyperoxia exposure on mitochondrial function in the developing kidney, 
especially since they also contain a large number of mitochondria due to their high aerobic 
capacity and their dysfunction is important in cardiovascular disease and hypertension52. 
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ABSTRACT 
Introduction: Rats exposed to oxygen (O2) as newborns suffer complications in adulthood, 
including: arterial hypertension, vascular dysfunction, nephropenia and indices of oxidative 
stress. Although the rats are born at term, their organ development is equivalent to that of a 
preterm fetus, allowing organs of interest such as the kidney to be compared to premature 
infants. Given that impaired nephrogenesis or reduced nephron numbers has been shown to 
promote the development of hypertension and mitochondrial dysfunction is associated with 
increased oxidative stress, we hypothesised that exposure to high oxygen concentrations in the 
neonatal period would significantly impact the expression and activity of key proteins involved 
in renal mitochondrial function and lead to an excessive production of reactive oxygen species 
by the mitochondria.  
Methods: Sprague-Dawley rat pups were exposed to 80% O2 (Hyperoxic (H) group; O2 exposed) 
or 21% O2 (Control (Ctrl) group) from day 3 to day 10 of life. At 4 and 16 weeks of age, kidneys 
were rapidly excised and the mitochondria isolated following a standard protocol; with a buffer 
containing 0.32 M sucrose and differential centrifugations. Expression of mitochondrial proteins 
was assessed by Western blot, whereas the release of hydrogen peroxide (H202), activities of key 
citric acid cycle enzymes and mitochondrial swelling were assessed by spectrophotometry. 
Results are expressed as the means ± SE. Both male and female offspring were studied. 
Results: In male H rats at 16 weeks of age, citrate synthase activity (used as an internal standard 
and a measure of relative mitochondrial abundance) was significantly increased (12.4 ± 8.4 vs 
4.1 ± 0.5), whereas aconitase activity (sensitive to ROS) was significantly decreased (0.11 ± 0.05 
vs 0.20 ± 0.04) and H202 release was significantly increased (7.0 ± 1.3 vs 5.4 ± 0.8) compared to 
the controls (Ctrl). The H group (vs Ctrl) also demonstrated a reduction in the expression of 
peroxiredoxin-3 (Prx3) (-23%), a protein involved in the elimination of H202 and in the expression 
of cytochrome C oxidase (Complex IV) (-15%), a protein in the mitochondrial respiratory chain, 
whereas the expression of uncoupling protein-2 (UCP2), a protein involved in dissipating the 
proton gradient, was significantly increased (+17%). Female H rats (vs Ctrl) at 16 weeks of age 
demonstrated a significant increase in aconitase activity (0.33±0.03 vs 0.17±0.02), in the 
expression of ATP synthase β subunit (+25%) (involved in ATP production) and in the expression 
of MnSOD (+20%) (mitochondrial antioxidant involved in scavenging superoxide), whereas Prx3 
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expression was significantly reduced (-24%).  In male H rats (vs Ctrl) at 4 weeks of age, the 
expression of Prx3 was significantly increased (+31%). Female H rats (vs Ctrl) at 4 weeks of age 
demonstrated a significant increase in the expression of UCP2 (+18%) and in the expression of 
MnSOD (+14%). 
Conclusion: The findings of this study demonstrate that transient oxygen exposure in the 
neonatal rat modifies protein expression, enzymatic activity and leads to indices of 
mitochondrial dysfunction (increase in ROS) in the adult kidney; these adverse changes in the 
mitochondria were more pronounced in adult males than in females. Overall, these findings, 
suggest that impaired mitochondrial function is associated with and could play a role in the 
development of arterial hypertension, oxidative stress and cardiovascular disease associated 
with transient neonatal hyperoxic stress. 
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INTRODUCTION 
Infants born prematurely at less than 37 weeks’ gestation account for over 8% of all births in 
Canada (up to 12% in the United States) and over 80% of infants weighing less than 2500 grams 
at birth (low birth weight infants)9, 83. Preterm neonates are exposed at birth to a high oxygen 
(O2) concentration relative to the intrauterine milieu
83. Of concern, the preterm infants possess 
a diminished and under-developed antioxidant capacity and are therefore more susceptible to 
the effects of reactive oxygen species (ROS)75, 83. This concept of premature newborns being 
more susceptible to oxidative tissue damage has been well established, with oxidative stress 
known to contribute to common pathologies such as retinopathy of prematurity and 
bronchopulmonary dysplasia9, 81. However the long term consequences of neonatal oxidative 
injury have only recently begun to be unravelled, and the mechanisms leading to long-term 
disease are to date not well understood83. 
 The concept that many adult conditions or diseases can have their origins traced back to fetal 
and early postnatal life has been termed ‘developmental programming’15. There are multiple 
insults or factors that can affect a developing fetus leading to the programming of adult diseases 
such as nutrition, oxidative stress and inflammation, glucocorticoid exposures, fetal hypoxia and 
epigenetic changes16. Revolutionary studies spanning several decades, with David Barker as the 
pioneering figure, demonstrated that impaired fetal growth is associated with raised blood 
pressure17, hypertension17 and cardiovascular mortality later in life in both male and female 
subjects168. This ‘fetal or developmental origins/programming of disease’ concept is now well 
accepted but the ‘programming’ mechanisms remain poorly understood26.  
Kidney development (nephrogenesis) begins at approximately day 30 of gestation, with the 
majority of nephrons being formed around week 20 until 34 to 36 weeks of gestation14. Given 
that nephrogenesis is still ongoing prior to 34 weeks of gestation, it is very likely that neonates 
born at less than 34 weeks of gestation will experience alterations in the structural development 
of the kidney14. In addition, the extrauterine environment is suboptimal for organogenesis due 
to the exposure to a number of insults, including high oxygen concentrations14. A previous study 
from our laboratory83 demonstrated that rats exposed to hyperoxia in the neonatal period led to 
a reduced nephron number, hypertension and vascular dysfunction in adulthood.  
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As mitochondria are also a major source of oxygen-derived free radicals, generated mainly as 
by-products of mitochondrial respiration, mitochondria are thought to be the primary target of 
oxidative damage169, 170. Mitochondria play a crucial role in energy metabolism through their 
involvement in ATP production by oxidative phosphorylation, and are thus often referred to as 
the powerhouse of the cell. After the oxidation of substrates in the citric acid cycle or Krebs 
cycle, the resulting electron carriers, NADH and FADH2, are oxidized by complexes I and II, 
respectively, which generates a proton gradient and ultimately drives the synthesis of ATP119, 170. 
Experimental studies have shown that specific enzymes of the citric acid cycle are susceptible to 
oxidation112, 171, 172. Aconitase exhibits the most significant age-associated decline in activity and 
is known to be highly susceptible to oxidation110 and increased citrate synthase activity has been 
suggested to contribute to progressive renal injury115. Apart from energy conversion, 
mitochondria take part in a number of other processes including calcium homeostasis and 
apoptosis151. It is well documented that an increased permeability of the mitochondrial 
membranes is a key event in controlling apoptotic pathways, with the permeability transition 
pore (PTP) thought to play a major role173-176. Prolonged opening of the PTP, a nonspecific high-
conductance proteinaceous channel of the inner membrane, leads to collapse of the membrane 
potential, mitochondrial matrix swelling, and rupture of the outer mitochondrial membrane157, 
158. 
Given the susceptibility of the mitochondria to oxidative stress, we hypothesised that exposure 
to high oxygen concentrations in the neonatal period would significantly impact the expression 
of key proteins involved in mitochondrial function and lead to an excessive production of 
reactive oxygen species by the mitochondria. The kidneys contain a large number of 
mitochondria due to their high aerobic capacity, they are important in cardiovascular disease, 
and hypertension is closely associated with progressive kidney dysfunction52. Therefore, the 
aims of the current study were to assess markers of mitochondrial protein expression and 
function in the kidney using a neonatal hyperoxic rat model. We examined the kidneys of rats 
exposed to hyperoxia (from P3 to P10) and compared them to normoxic controls at both 4 and 
16 weeks of age. 
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METHODS 
Animals 
All experiments on animals were performed in accordance to the guidelines approved by the 
Animal Care Committee of Sainte-Justine University Hospital Center and conform with the 
objectives of the Canadian Council on Animal Care. 
Sprague-Dawley rat pups (Charles River, St-Constant, Québec, Canada) were exposed to 80% O2 
(mixture of medical-grade 100% O2 and room air; ProOx oxygen controller, A820CV, Biospherix) 
from day 3 to day 10 of life (Hyperoxic (H) group; O2 exposed). To avoid maternal mortality 
associated with high O2 exposure, the dam was alternated every 12 hours with a surrogate 
mother of a different litter. Control litters were kept in room air, and the dam was not 
interchanged (Control (Ctrl) group).  After P10, all litters were returned to room air. Pups were 
weaned at 4 weeks of age to regular chow. Both male and female offspring were studied at 4 
and 16 weeks. No more than 2 animals per gender per litter were used for each series of studies 
with a total of 3 litters. 
Mitochondrial isolation 
Kidney mitochondria were isolated according to a protocol adapted from Fernandez-Vizarra et 
al.118 Animals were anaesthetized via inhaled isoflurane (2- :1.5 O2) and then euthanized by 
guillotine. Kidneys were rapidly excised, medullas removed, weighed and the cortex immersed 
into ice cold isolation buffer (0.32 M sucrose, 1mM EDTA, 10 mM Tris, pH 7.4). All steps were 
performed on ice and centrifugations were performed at 4⁰C. Kidney tissue was homogenized 
using a Potter-Elvehjem tissue grinder on maximum speed setting (for approximately 10 s). The 
homogenate was centrifuged at 1000g for 10 mins, followed by the supernatant being decanted 
and again centrifuged as above. The resultant supernatant was then centrifuged at 18 000g for 
15 mins. The supernatant was discarded and the pellet was resuspended in 5 mL fresh isolation 
buffer, and centrifuged at 18 000g for 15 mins. The final mitochondrial pellets were 
resuspended in 2 mL isolation buffer and protein determinations were performed by the 
Bradford assay method with BSA (1.42 μg/μL) used as the standard. 
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Western Blot  
Precast 4-12% NUPAGE Bis Tris Gels (Invitrogen) containing 40 μg of protein per well were 
transferred overnight to polyvinylidine fluoride (PVDF) membranes. Membranes were blocked 
for 1 hr at room temperature with 5% TBST/milk solution. Membranes were then incubated 
with primary monoclonal antibodies for 1.5 hrs. All primary antibodies were diluted to 1 :1000 
unless otherwise noted : (UCP2-calbiochem, Billerica, MA),  Peroxiredoxin-3 (Abcam), ATP 
synthase β (1 :3000, MitoSciences), cytochrome c oxidase subunit 1 (complex 4)-(MitoSciences), 
ubiquinol cytochrome c oxidoreductase core 2 subunit (Mitosciences), LDH (Abcam), anti-Cox  IV 
antibody (internal reference protein, Abcam), anti-catalase (Abcam), MnSOD (1 :10 000, 
Stressgen). The secondary antibodies goat anti-rabbit and goat anti-mouse (1 : 15 000, Santa 
Cruz) were used according to the primary antibodies. Bands were visualized using an enhanced 
chemiluminescence method, ECL plus (Perkin Elmer, MA, USA). Films were scanned using a 
flatbed scanner, and images analyzed with Gel Pro analyser 3.1 (Media Cybernetics, MD, USA). 
Results were normalized to anti-COX IV (1 :1000, Abcam) or voltage-dependent anion channel 
(VDAC, 1 :10 000, Enzo Life Sciences) for loading variations. 
Citrate Synthase Enzymatic Activity Assays 
Total protein content was determined using a Bradford assay. For the assay, 100 μg of total 
protein was used per well. Enzymatic activity was determined using the citrate synthase assay 
kit (Sigma, St. Louis, Missouri) with slight modifications. The Absorbance readings at 412 nm 
were taken using an Envision 2104 Multilabel Reader spectrophotometer (Perkin Elmer, 
Waltham, Massachusetts) with 9 readings over the 1.5 min time span. The difference between 
baseline and oxaloacetate (OAA)-treated samples was obtained and used to calculate total 
citrate synthase activity according to the formula provided by the manufacturer.   
Aconitase Activity 
Aconitase activity kit (Mitosciences (MS745), Eugene, Oregon) was used. Aconitase activity is 
measured by following the conversion of isocitrate to cis aconitate through the increase of 
absorbance at 240 nm. Samples were diluted to a concentration of 5 μg/μL and assessed at 60 
second intervals for 30 minutes. 
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H2O2 production 
Mitochondrial H202 production was determined by absorbance at 560 nm (Envision 2104 
Multilabel Reader; Perkin Elmer) using Amplex red (Molecular Probes, Eugene, OR). Amplex red 
reacts with H2O2 in a 1:1 stoichiometry to produce highly coloured resorufin. Briefly, 100 µM 
Amplex red reagent and 0.2 U/ml horseradish peroxidase were added to the mitochondrial 
sample (50 µl) or H2O2 standard solution, and the sample was incubated for 30 mins in a 96-well 
microplate in the dark at room temperature. H2O2 concentrations were calculated on the basis 
of an H2O2 standard curve generated using H2O2 and Amplex red. 
Mitochondrial Swelling (PTP opening)  
Mitochondrial swelling was estimated through changes in OD540 nm recorded using an Envision 
2104 Multilabel Reader (Perkin Elmer) spectrophotometer using a protocol adapted from 
Gogvadze et al177 in Current Protocols in Cell Biology. The gradual decrease in OD540 nm due to 
mitochondrial swelling was analyzed at 1 minute intervals for 1 hr following the addition of 
calcium and other reagents to the mitochondrial suspension concentrated at 10 μg/μL. All 
measurements were performed at 25⁰C.  
Statistical Analysis 
Data is expressed as the means ± SE. Differences between groups were compared using two-
tailed Student’s t-test. Mitochondrial swelling was assessed by the two-way repeated-measures 
ANOVA with the factors hyperoxia exposure (pH), time point of assessment (pT) and their 
interaction (pHxT). Statistical analyses were performed using GraphPad Prism version 5.03 for 
Windows (CA, U.S.A). A difference of P ≤ 0.05 was considered significant. 
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RESULTS 
Enzymatic Activity of Citrate Synthase  
The activity of citrate synthase was significantly increased in male rats exposed to hyperoxia (H) 
compared to the controls (Ctrl, p0.05) at 16 weeks (Figure 1A). There was no significant 
difference between female experimental groups at 16 weeks (Figure 1B). No significant 
difference was observed between experimental groups in either males or females at 4 weeks of 
age (Figure 1C-D). 
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Figure 1: Citrate Synthase Activity.  Citrate synthase activity (μmol/mL/min) in kidneys from 16 
week old adult male (A) and female (B) rats, and 4 week old male (C) and female (D) rats 
exposed to high oxygen (80% O2) from day 3 to 10 of life (H, n=6 per group) vs. room air controls 
(Ctrl, n=6 per group). *=p≤ 0.05 
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Enzymatic Activity of Aconitase 
The activity of aconitase was significantly decreased in male rats exposed to hyperoxia 
compared to the controls (p0.05) at 16 weeks (Figure 2A). Conversely, aconitase activity was 
significantly increased in females exposed to hyperoxia, at 16 weeks, compared to the controls 
(p0.01; Figure 2B). No significant difference in aconitase activity was observed between 
experimental groups in either males or females at 4 weeks of age (Figure 2C-D).  
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Figure 2: Aconitase Activity.  Aconitase activity (μmol/min/mg mitochondria) in kidneys from 16 
week old adult male (A) and female (B) rats , and 4 week old male (C) and female (D) rats 
exposed to high oxygen (80% O2) from day 3 to 10 of life (H, n=6 per group) vs. room air controls 
(Ctrl, n=6 per group). *=p≤ 0.05; **=p≤ 0.01 
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Protein Expression of Complex 3 
No significant difference in the protein expression of complex 3 was observed between 
experimental groups in either males or females at 16 weeks (Figure 3A-B) or at 4 weeks of age 
(Figure 3C-D). 
 
 
Ctrl H 
0.0
0.5
1.0
1.5
Ctrl H
Groups
C
om
pl
ex
 3
/C
O
X 
4 
R
at
io
Ctrl H 
0.0
0.5
1.0
1.5
Ctrl H
Groups
C
om
pl
ex
 3
/C
O
X 
4 
R
at
io
Ctrl H
0.0
0.5
1.0
1.5
Ctrl H
Groups
C
om
pl
ex
 3
/C
O
X 
4 
R
at
io
Ctrl H
0.0
0.5
1.0
1.5
Groups
C
om
pl
ex
 3
/C
O
X 
4 
R
at
io
Ctrl H
A B
C D
 
Figure 3: Complex 3 Protein Expression.  Complex 3 protein expression (assessed by Western 
blotting and expressed as a ratio of COX4 expression; see Methods) in kidneys from 16 week old 
adult male (A) and female (B) rats, and 4 week old male (C) and female (D) rats exposed to high 
oxygen (80% O2) from day 3 to 10 of life (H, n=6 per group) vs room air controls (Ctrl, n=6 per 
group).  
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Protein Expression of Complex 4 
The expression of complex 4 was found to be significantly decreased in male rats exposed to 
hyperoxia compared to the controls (p0.01) at 16 weeks of age (Figure 4A). In females at 16 
weeks of age (Figure 4B) and in both males and females at 4 weeks of age (Figure 4C-D), no 
significant difference was observed between groups. 
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Figure 4: Complex 4  Protein Expression.  Complex 4 protein expression (assessed by Western 
blotting and expressed as a ratio of VDAC or COX 4 expression; see Methods) in kidneys from 16 
week old adult male (A) and female (B) rats, and 4 week old male (C) and female (D) rats 
exposed to high oxygen (80% O2) from day 3 to 10 of life (H, n=7 males and n=9 females) vs. 
room air controls (Ctrl, n=7 per group). **=p≤ 0.01 
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Protein Expression of ATP Synthase β subunit 
The expression of ATP synthase β was found to be significantly increased in female rats exposed 
to hyperoxia compared to the controls (p0.01) at 16 weeks of age (Figure 5B). In males at 16 
weeks of age (Figure 5A), and both males and females at 4 weeks of age (Figure 5C-D), no 
significant difference was observed between groups. 
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Figure 5: ATP synthase β subunit Protein Expression.  ATP synthase β subunit protein 
expression (assessed by Western blotting and expressed as a ratio of COX4 expression; see 
Methods) in kidneys from 16 week old adult male (A) and female (B) rats, and 4 week old male 
(C) and female (D) rats exposed to high oxygen (80% O2) from day 3 to 10 of life (H, n=6 per 
group) vs. room air controls (Ctrl, n=6 per group). **=p≤ 0.01 
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Protein Expression of Uncoupling Protein-2 
At 16 weeks of age, uncoupling protein-2 (UCP2) expression was significantly increased in male 
hyperoxia-exposed rats compared to the controls (p0.01) (Figure 6A), while no significant 
difference was observed between groups in females (Figure 6B).  At 4 weeks of age, UCP2 
expression was significantly increased in female hyperoxia-exposed rats compared to the 
controls (p0.05; Figure 6D), while no significant difference was observed between the 
experimental groups in males (Figure 6C).  
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Figure 6: Uncoupling Protein 2 (UCP2) Protein Expression.  Uncoupling Protein-2 (UCP2) protein 
expression (assessed by Western blotting and expressed as a ratio of COX4 expression; see 
Methods) in kidneys from 16 week old adult male (A) and female (B) rats, and 4 week old male 
(C) and female (D) rats exposed to high oxygen (80% O2) from day 3 to 10 of life (H, n=6 per 
group) vs. room air controls (Ctrl, n=6 per group). *=p≤ 0.05; **=p≤0.01 
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Protein Expression of Manganese Superoxide Dismutase 
Protein expression of mitochondrial manganese superoxide dismutase MnSOD was found to be 
significantly increased in females exposed to hyperoxia at both 16 weeks of age (p0.01; Figure 
7B) and 4 weeks of age (p0.05; Figure 7D) compared to the controls. No significant difference 
was observed between the groups in males at both 16 and 4 weeks of age (Figure 7A, C). 
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Figure 7: MnSOD Protein Expression.  Manganese superoxide dismutase (MnSOD) protein 
expression (assessed by Western blotting and expressed as a ratio of COX4 expression; see 
Methods) in kidneys from 16 week old adult male (A) and female (B) rats, and 4 week old male 
(C) and female (D) rats exposed to high oxygen (80% O2) from day 3 to 10 of life (H, n=6 per 
group) vs. room air controls (Ctrl, n=6 per group). *=p≤ 0.05; **=p≤ 0.01 
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Protein Expression of Catalase  
No significant difference was observed between experimental groups in the protein expression 
of catalase, in either males or females, at 16 weeks (Figure 8A-B) or 4 weeks of age (Figure 8C-
D). 
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Figure 8: Catalase Protein Expression.  Catalase protein expression (assessed by Western 
blotting and expressed as a ratio of COX4 expression; see Methods) in kidneys from 16 week old 
adult male (A) and female (B) rats, and 4 week old male (C) and female (D) rats exposed to high 
oxygen (80% O2) from day 3 to 10 of life (H, n=6 per group) vs. room air controls (Ctrl, n=6 per 
group). 
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Protein Expression of Peroxiredoxin-3  
At 16 weeks of age, the protein expression of peroxiredoxin-3 (Prx3) was found to be 
significantly decreased in the groups exposed to hyperoxia compared to the control groups 
(p0.05), in both males (Figure 9A) and females (Figure 9B). At 4 weeks of age, Prx3 expression 
was significantly increased in males exposed to hyperoxia (p≤0.05; Figure 9C), while no 
difference was observed between the groups in females (Figure 9D).  
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Figure 9: Peroxiredoxin-3 (Prx3) Protein Expression at 16 weeks.  Peroxiredoxin-3 (Prx3) 
protein expression (assessed by Western blotting and expressed as a ratio of VDAC or COX 4 
expression; see Methods) in kidneys from 16 week old adult male (A) and female (B) rats, and 4 
week old male (C) and female (D) rats exposed to high oxygen (80% O2) from day 3 to 10 of life 
(H, n=6 per group) vs. room air controls (Ctrl, n=6 males and 4 females). *=p≤ 0.05 
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Levels of Hydrogen Peroxide (H202) Release 
Hydrogen peroxide release was significantly increased in hyperoxia-exposed males compared to 
the controls (p0.05) at 16 weeks of age (Figure 10A), whereas females showed a trend for an 
increase that did not quite reach statistical significance (Figure 10B). At 4 weeks of age, no 
significant difference between the groups was observed in either males or females (Figure 10C-
D). 
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Figure 10: H202 Release (Amplex Red).  Hydrogen peroxide (H202) release in kidneys from 16 
week old adult male (A) and female (B) rats, and 4 week old male (C) and female (D) rats 
exposed to high oxygen (80% O2) from day 3 to 10 of life (H, n=7 per group) vs. room air controls 
(Ctrl, n=6 males and 4 females). *=p≤ 0.05 
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Mitochondrial Permeability Transition Pore Opening 
Opening of the mitochondrial permeability transition pore was induced with the addition of 
Ca2+, and specrophotometrically monitored at 540 nm for 20 min. In mitochondria isolated from 
4 week old male rat kidneys, the addition of Ca2+ resulted in a significant decrease in absorbance 
which is indicative of mitochondrial swelling (Figure 11). There was no significant difference in 
mitochondrial swelling between hyperoxia-exposed and control animals at any timepoint.   
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Figure 11: Mitochondrial Swelling at 4 weeks.  Squares: Hyperoxic group (H; n=5). Triangles: 
Control group (Ctrl; n=6). Factors assessed using two-way ANOVA with repeated measures were 
time (pT<0.0001), hyperoxia exposure (pH=0.31) and their interaction (pTxH=0.49). Bonferroni 
post-hoc analysis showed no significant differences between hyperoxia (H) and control (Ctrl) 
groups at any individual timepoint. 
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DISCUSSION 
Results of this study indicate that hyperoxic exposure of newborns modifies protein expression, 
enzymatic activity and leads to indices of mitochondrial dysfunction (increase in ROS) in the 
adult kidney; these adverse changes in the mitochondria were more pronounced in adult males 
than in females. Previous findings in our rodent model demonstrate that transient neonatal 
hyperoxia exposure leads to reduced nephron number, vascular dysfunction, and the 
development of hypertension in adulthood46. The mechanisms leading to the programming of 
hypertension in this model are unknown, but it was hypothesised that alterations in 
mitochondrial function would be a contributing factor. Hyperoxia has been shown in several 
previous studies to adversely affect mitochondrial metabolism.  Citric acid cycle enzymes 
important in mitochondrial function have been shown to decline in activity, with aconitase 
exhibiting the most significant age-associated decline in activity110. Electron transport chain 
components have also been shown to be affected, along with a decrease in cellular ATP159, 160. In 
addition, the antioxidants MnSOD, GPx and catalase have all been shown to have decreased 
levels when exposed to neonatal hyperoxia or other toxins157, 164-166. Consistent with these 
previous studies, the current findings demonstrate that mitochondrial function is impaired in 
the adult rat kidney following neonatal oxygen exposure; components of the citric acid cycle, 
electron transport chain, and antioxidant levels are all adversely affected.  
In males at 16 weeks of age enzymatic assays of both citrate synthase activity and aconitase 
activity demonstrated significant differences between groups. To further assess protein targets 
of the ageing process in mitochondria, enzymatic activity of citrate synthase was determined. 
Citrate synthase activity was found to be significantly increased in the hyperoxia exposed group 
compared to the control, whereas aconitase activity was found to be significantly decreased. A 
decrease in aconitase activity is likely to adversely affect the remaining portions of the citric acid 
cycle, thereby decreasing its overall efficiency (see Figure 6). Furthermore, aconitase has been 
shown to be highly sensitive to ROS, indicating levels of dysfunction in mitochondrial 
metabolism110. Normally intermediates produced in the citric acid cycle do not accumulate in 
the mitochondria, and are exported to the cytosol. The accumulation of citrate in the cytosol 
would likely activate fatty acid synthesis110. The activation of fatty acid synthesis can lead to 
reduced insulin sensitivity, cardiovascular disease and type 2 diabetes; all characteristics of 
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metabolic syndrome178. In contrast to the findings in males, females at 16 weeks of age 
demonstrated a significant increase in the activity of aconitase in the hyperoxia exposed group 
compared to the control suggesting that there is a protective effect in females.  No significant 
difference in enzymatic activity was observed at 4 weeks of age between groups in either males 
or females, indicating that this may be a process related to ageing as hyperoxia-exposed animals 
are more susceptible to accelerated ageing. 
At 16 weeks of age several differences were observed in the level of protein expression in 
various components of the electron transport chain and respiratory chain. Males showed a 
significant decrease in complex 4 expression in the hyperoxia exposed group compared to the 
control, whereas a significant increase in protein expression of UCP2 was observed. It is possible 
that reduction in complex 4 protein or subunit content contributes to adverse effects on energy 
production, and complex activities by impairing supercomplex formation. This is similar to what 
is seen in people with a dietary copper (Cu) deficiency179. The increase in UCP2 expression can 
potentially be attributed to ROS, which have been shown to increase proton conductance over 
the mitochondrial membrane by activation of UCPs as a possible mechanism to decrease 
prevalent free radicals and their effects in the cell180. No significant differences were observed in 
the expression of complex 3 or the ATP synthase β subunit between male groups. Females, 
however,  showed an increase in the expression of ATP synthase β subunit at 16 weeks which 
suggests a possible increase in energy metabolism in the group exposed to hyperoxia. No 
significant differences were observed in protein expression levels of complex 3, complex 4 and 
UCP2 in females at 16 weeks of age. UCP2 expression in females exposed to hyperoxia was 
found to be significantly increased compared to the control group at 4 weeks of age. The reason 
for the differences in expression between 4 and 16 weeks is unclear, however, it may in part be 
due to a short-term protective effect to dissipate ATP production and by doing so, limit ROS 
production following oxidative insult, thus stabilizing long-term function. No other significant 
differences were observed in the assessed proteins in males or females at 4 weeks of age. 
At 16 weeks in males the present study demonstrates a significant difference in ROS production, 
measured as H202, between groups. The group exposed to hyperoxia was shown to have 
markedly increased ROS production, in tandem with decreased Prx3 expression demonstrating 
indices of dysfunction and a reduced capacity to eliminate the excess ROS. This may potentially 
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cause a vicious cycle, leading to amplified effects and endangering cell function. In females, 
MnSOD antioxidant expression was significantly increased at 4 weeks of age and even more so 
at 16 weeks of age in the group exposed to hyperoxia, suggesting that females are better able to 
deal with ROS than males, as hydrogen peroxide levels in females showed no significant 
difference between the groups. Prx3 expression, however, was found to be significantly 
decreased in females at 16 weeks of age compared to the control, while no significant difference 
was observed at 4 weeks. Interestingly, in males, Prx3 expression was found to be significantly 
increased at 4 weeks of age and significantly decreased at 16 weeks of age. A possible 
explanation for this may be that in the short term, oxidative stress induces Prx3 expression and 
in the long term it becomes depleted. No significant difference was observed in the protein 
expression of catalase in males or females at either timepoint. Since catalase is present in very 
low concentrations in mitochondria181 it is not surprising that no significant difference was 
observed between groups. No other significant differences were observed between groups in 
the assessed antioxidants and ROS levels. 
Previous studies have shown that males have an increased sensitivity to oxidative stress 
compared to females182-185. Females have been shown to have a lower level of oxidative damage 
to DNA than males182. Possible explanations include the antioxidant properties of estrogen 
although the exact mechanism remains unknown186. Other antioxidant-related factors are also 
thought to contribute to gender-related differences in antioxidant protection; however, nothing 
concrete has yet been determined182. Our findings demonstrate an increase in the quantity of 
MnSOD (an antioxidant enzyme specific to the mitochondria responsible for neutralizing 
superoxide free radical) in females exposed to hyperoxia compared to the control, 
demonstrating a protective effect which is in accordance with previous studies showing 
increased activity of antioxidant systems in females186-188. The precise mechanisms for the 
observed difference in renal antioxidant capacity would require more experiments, as presently 
the mechanism remains unknown. 
As described by Nuyt et al.16, programming occurs when the normal pattern of development is 
disrupted by an abnormal stimulus or ‘insult’ applied at a critical time-point. This leads to an 
adaptive structural or functional response in the fetus/neonate that promotes short-term 
survival, but which may manifest in adult disease (such as diabetes or hypertension) in later life. 
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Importantly, Yzydorczyk et al.83 demonstrated a reduced nephron number and hypertension in 
adult rats following a transient neonatal hyperoxic insult (at a time when renal development 
was still ongoing), however the mechanisms underlying the programming of hypertension in this 
model are unknown. It was hypothesised that alterations in mitochondrial function may be a 
contributing factor in the development of hypertension; hyperoxia is known to lead to 
mitochondrial dysfunction189 which in turn may adversely affect mitochondrial metabolism 
(increased levels of oxidative stress and decreased levels of antioxidant enzymes) and result in 
hypertension189. In the study by Yzydorczyk et al.83, hypertension was only evident in adult 
animals at 8 weeks of age; therefore, to evaluate the role of mitochondria in the development 
of hypertension, in the current study it was important to look at timepoints both prior to the 
onset of hypertension (4 weeks) and after the onset of hypertension (16 weeks). If an effect is 
present at 4 weeks (early-onset), it may precede and potentially contribute to the development 
of hypertension and likely occurred as a direct consequence of hyperoxia exposure, whereas, if 
an effect is only present at 16 weeks (after the onset of hypertension), it may not be a 
contributing factor and it is difficult to tell if the effect is a consequence of hyperoxia exposure, 
or due to the later complications (such as hypertension or ageing). In assessing males and 
females at 4 and 16 weeks of age, we were better able to deduce if the changes in 
mitochondrial metabolism were due to programming or injury. In females, there seems to be 
both a programming aspect and a possible injury phenomenon that could affect mtDNA. The 
expression of MnSOD, which is a mitochondrial antioxidant, is significantly increased at 4 weeks 
of age (preceding the onset of hypertension)  in the hyperoxia exposed group compared to 
control and even more so at 16 weeks of age (after the onset of hypertension/age), 
demonstrating a potential protective programming effect. In addition, the significant increase in 
UCP2 expression at 4 weeks of age in the hyperoxia exposed group may potentially serve to 
minimize ROS damage in older females, as no significant difference was observed at 16 weeks of 
age between groups. However, the expression of Prx3 seems to be brought about through injury 
instead of by programming, since Prx3 expression (a ROS scavenger) is significantly decreased at 
16 weeks of age (in the group exposed to hyperoxia) but no significant difference was observed 
at 4 weeks of age, indicating a possible age-related or hypertension-related onset. In addition, 
aconitase activity is significantly increased at 16 weeks of age in the hyperoxia exposed group, 
suggesting a protective effect. This increase was not seen at 4 weeks of age (possible change 
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after onset of hypertension/ageing). Finally, ATP synthase β subunit (involved in ATP 
production) expression was found to be significantly increased at 16 weeks of age but not at 4 
weeks of age, suggesting the possible role of injury to mitochondria instead of a programming 
effect. Therefore, in females, there seems to be evidence for both a programming effect and an 
effect possibly due to injury as a secondary effect to the development of hypertension. In males, 
the results seem to indicate more of an injury effect rather than a programming effect. Citric 
acid cycle enzymatic activity was significantly affected at 16 weeks of age, compared to no 
significant difference between groups at 4 weeks of age. This trend was also observed for 
complex 4 and UCP2 protein expression and for in males. However, Prx3 expression seems to 
follow a programming effect. In males (exposed to hyperoxia) at 4 weeks of age, Prx3 expression 
was significantly increased as a possible short-term compensatory mechanism to deal with 
oxidative insult and significantly decreased at 16 weeks of age as Prx3 potentially becomes 
depleted. 
In conclusion, this study demonstrates that there appears to be differences in mitochondrial 
metabolism in the kidneys between males and females following oxidative insult with the 
potential dual roles of programming (following the neonatal hyperoxia exposure) and injury 
(following the onset of hypertension) as a possible mechanism for the observed disease 
phenotype. Furthermore, the observed sex difference indicates that females may be better able 
to cope with oxidative insult than males, which is a recognized fact in the neonatal period. 
Overall, the findings of this study have shown that neonatal hyperoxia exposure alters renal 
mitochondrial function in adulthood; however, future studies are required in order to deduce 
the mechanism responsible for the disease phenotype, and what exact role mitochondria may 
play in the programming of renal dysfunction and hypertension.  
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3.0 DISCUSSION 
The findings of this study demonstrate that transient oxygen exposure in the neonatal rat modifies 
protein expression, enzymatic activity and leads to indices of mitochondrial dysfunction (increase 
in ROS) in the adult kidney; these adverse changes in the mitochondria were more pronounced in 
adult males than in females. Males exposed to hyperoxia (vs Ctrl) demonstrated greater levels of 
mitochondrial dysfunction (adversely affected citric acid cycle enzymatic activity, significantly 
higher levels of H2O2) at 16 weeks compared to males at 4 weeks and compared to females at both 
ages. On the other hand, females exposed to hyperoxia (vs Ctrl), showed significantly higher levels 
of MnSOD antioxidant expression at 4 weeks, with an even greater expression at 16 weeks. 
Overall, these findings, suggest a possible role of impaired mitochondrial function following 
hyperoxia exposure in the development of arterial hypertension, accelerated ageing and 
cardiovascular disease. 
Previous findings in our rodent model demonstrate that transient neonatal hyperoxia exposure 
leads to reduced nephron number, vascular dysfunction, and the development of hypertension in 
adulthood46. The mechanisms leading to the programming of hypertension in this model are 
incompletely known, but it was hypothesised that alterations in mitochondrial function would be a 
contributing factor. Hyperoxia has been shown in several previous studies to adversely affect 
mitochondrial metabolism.  Citric acid cycle enzymes important in mitochondrial function have 
been shown to decline in activity, with aconitase exhibiting the most significant age-associated 
decline in activity, and the NADPH :NADP+ ratio also declines with age110. Electron transport chain 
components have also been shown to be affected by hyperoxia, along with a decrease in cellular 
ATP159, 160. In addition, the antioxidants MnSOD, GPx and catalase have all been shown to have 
decreased levels when exposed to neonatal hyperoxia or other toxins, in erythrocytes, in the brain 
and in the liver 157, 164-166. Consistent with these previous studies, the current findings reported in 
this thesis demonstrate that mitochondrial function is impaired in the adult rat kidney following 
neonatal oxygen exposure; components of the citric acid cycle, electron transport chain, and 
antioxidant levels are all adversely affected. This research will therefore go some way to further 
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understand this organelle’s potential role in the development of hypertension and cardiovascular 
disease. 
 
3.1 Summary of Main Findings 
3.1.1  Citric Acid Cycle 
In males at 16 weeks of age enzymatic assays of both citrate synthase activity and aconitase 
activity demonstrated significant differences between groups. To further assess protein targets of 
the ageing process in mitochondria, enzymatic activity of citrate synthase was determined. Citrate 
synthase activity was found to be significantly increased in the hyperoxia exposed group compared 
to the control, whereas aconitase activity was found to be significantly decreased. A decrease in 
aconitase activity is likely to adversely affect the remaining portions of the citric acid cycle, thereby 
decreasing its overall efficiency (see Figure 6). Furthermore, aconitase has been shown to be 
highly sensitive to ROS, indicating levels of dysfunction in mitochondrial metabolism110. Normally 
intermediates produced in the citric acid cycle do not accumulate in the mitochondria, and are 
exported to the cytosol. The accumulation of citrate in the cytosol would likely activate fatty acid 
synthesis110. The activation of fatty acid synthesis can lead to reduced insulin sensitivity, 
cardiovascular disease and type 2 diabetes; all characteristics of metabolic syndrome178. In 
contrast to the findings in males, females at 16 weeks of age demonstrated a significant increase 
in the activity of aconitase in the hyperoxia exposed group compared to the control suggesting 
that there is a protective effect in females.  No significant difference in enzymatic activity was 
observed at 4 weeks of age between groups in either males or females, indicating that this may be 
a process related to ageing as hyperoxia-exposed animals are more susceptible to accelerated 
ageing or related to the elevated blood pressure, present at 16 weeks but not at 4 weeks83. 
 
3.1.2  Electron Transport Chain (ATP/Energy) 
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At 16 weeks of age several differences were observed in the level of protein expression in various 
components of the electron transport chain and respiratory chain. Males showed a significant 
decrease in complex IV expression in the hyperoxia exposed group compared to the control, 
whereas a significant increase in protein expression of UCP2 was observed. It is possible that 
reduction in complex IV protein or subunit content contributes to adverse effects on energy 
production, and complex activities by impairing supercomplex formation. This is similar to what is 
seen in people with a dietary copper (Cu) deficiency179. The increase in UCP2 expression can 
potentially be attributed to ROS, which have been shown to increase proton conductance over the 
mitochondrial membrane by activation of UCPs as a possible mechanism to decrease prevalent 
free radicals and their effects in the cell180. No significant differences were observed in the 
expression of complex III or the ATP synthase β subunit between male groups. Females, however,  
showed an increase in the expression of ATP synthase β subunit at 16 weeks which suggests a 
possible increase in energy metabolism in the group exposed to hyperoxia. No significant 
differences were observed in protein expression levels of complex III, complex IV and UCP2 in 
females at 16 weeks of age. However at 4 weeks of age, UCP2 expression in females exposed to 
hyperoxia was found to be significantly increased compared to the control group. The current 
studies cannot provide an explanation for the differences in expression observed between 4 and 
16 weeks, however, it may in part be due to a short-term protective effect to dissipate ATP 
production and by doing so, limit ROS production following oxidative insult, thus stabilizing long-
term function. No other significant differences were observed in the assessed proteins in males or 
females at 4 weeks of age. 
 
3.1.3  Antioxidants/Oxidants 
At 16 weeks in males the present study demonstrates a significant difference in ROS production, 
measured as H202, between groups. The group exposed to hyperoxia was shown to have markedly 
increased H202 levels, in tandem with decreased Prx3 expression demonstrating indices of 
dysfunction and a reduced capacity to eliminate the excess ROS. This may potentially cause a 
vicious cycle, leading to amplified effects and endangering cell function. In females, MnSOD 
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antioxidant expression was significantly increased at 4 weeks of age and even more so at 16 weeks 
of age in the group exposed to hyperoxia, suggesting that females are better able to deal with ROS 
than males, as hydrogen peroxide levels in females showed no significant difference between the 
groups. Prx3 expression, however, was found to be significantly decreased in females at 16 weeks 
of age compared to the control, while no significant difference was observed at 4 weeks. 
Interestingly, in males, Prx3 expression was found to be significantly increased at 4 weeks of age 
and significantly decreased at 16 weeks of age. A possible explanation for this may be that in the 
short term, oxidative stress induces Prx3 expression and in the long term it becomes depleted. No 
significant difference was observed in the protein expression of catalase in males or females at 
either timepoint. Since catalase is present in very low concentrations in mitochondria181 it is not 
surprising that no significant difference was observed between groups with the method of 
detection used for the current studies. No other significant differences were observed between 
groups in the assessed antioxidants (MnSOD, Prx3, catalase) and H202 levels. 
 
3.1.4  NADPH/NADP+ ratio 
NADPH/NADP+ ratio is an important indicator of the redox balance of the cell. A decrease in this 
ratio has been shown to favor a pro-oxidant state in kidney mitochondria110. Unfortunately, there 
was a problem with the company which supplied the protocol for this assay and the results were 
unable to be interpreted. This is an important test for evaluating mitochondrial function and will 
be repeated in future studies. 
 
3.1.5  Mitochondrial swelling (PTP) 
Mitochondrial swelling following calcium-induced opening of the PTP, a measure of mitochondrial 
dysfunction, was assessed in males at 4 weeks of age. Contrary to our hypothesis, no significant 
difference was observed between groups which indicates that the sensitivity of the PTP to calcium 
was not altered following hyperoxia exposure. It is possible that the animals studied were still 
relatively young and therefore that overt mitochondria dysfunction was not (yet) detectable. 
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Similarly, it could be hypothesized that PTP opening is normal in baseline conditions but becomes 
impaired in situation of additional challenge such as more pronounced hypertension, 
inflammation, etc. 
 
3.2 Male and female differences 
Previous studies have shown that males have an increased sensitivity to oxidative stress compared 
to females182-185. Females have been shown to have a lower level of oxidative damage to DNA than 
males182. Possible explanations include the antioxidant properties of estrogen although the exact 
mechanism remains unknown186. Other antioxidant-related factors are also thought to contribute 
to gender-related differences in antioxidant protection; however, nothing concrete has yet been 
determined182. Our findings demonstrate an increase in the quantity of MnSOD (an antioxidant 
enzyme specific to the mitochondria responsible for neutralizing superoxide free radical) in 
females exposed to hyperoxia compared to the control, demonstrating a protective effect which is 
in accordance with previous studies showing increased activity of antioxidant systems in 
females186-188. The precise mechanisms for the observed difference in renal antioxidant capacity 
would require more experiments, as presently the mechanism remains incompletely known. 
 
3.3 Relation to programming of hypertension 
As described by Nuyt et al.16, programming occurs when the normal pattern of development is 
disrupted by an abnormal stimulus or ‘insult’ applied at a critical time-point. This leads to an 
adaptive structural or functional response in the fetus/neonate that promotes short-term survival, 
but which may manifest in adult disease (such as diabetes or hypertension) in later life. 
Importantly, Yzydorczyk et al.83 demonstrated a reduced nephron number and hypertension in 
adult rats following a transient neonatal hyperoxic insult (at a time when renal development was 
still ongoing), however the mechanisms underlying the programming of hypertension in this 
model are unknown. It was hypothesised that alterations in mitochondrial function may be a 
contributing factor in the development of hypertension; hyperoxia is known to lead to 
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mitochondrial dysfunction189 which in turn may adversely affect mitochondrial metabolism 
(increased levels of oxidative stress and decreased levels of antioxidant enzymes) and result in 
hypertension189. In the study by Yzydorczyk et al.83, hypertension was only evident in adult animals 
at 8 weeks of age; therefore, to evaluate the role of mitochondria in the development of 
hypertension, in the current study it was important to look at timepoints both prior to the onset of 
hypertension (4 weeks) and after the onset of hypertension (16 weeks). If an effect is present at 4 
weeks (early-onset), it may precede and potentially contribute to the development of 
hypertension and likely occurred as a direct consequence of hyperoxia exposure, whereas, if an 
effect is only present at 16 weeks (after the onset of hypertension), it may not be a contributing 
factor and it is difficult to interpret whether the effect is a consequence of hyperoxia exposure, or 
due to the later complications (such as hypertension or ageing). In assessing males and females at 
4 and 16 weeks of age, we were better able to deduce if the changes in mitochondrial metabolism 
were due to programming or injury. In females, there seems to be both a programming aspect and 
a possible injury phenomenon that could affect mtDNA. The expression of MnSOD, which is a 
mitochondrial antioxidant, is significantly increased at 4 weeks of age (preceding the onset of 
hypertension)  in the hyperoxia exposed group compared to control and even more so at 16 weeks 
of age (after the onset of hypertension/age), demonstrating a potential protective programming 
effect. In addition, the significant increase in UCP2 expression at 4 weeks of age in the hyperoxia 
exposed group may potentially serve to minimize ROS damage in older females, as no significant 
difference was observed at 16 weeks of age between groups. However, the expression of Prx3 
seems to be brought about through injury instead of by programming, since Prx3 expression (a 
ROS scavenger) is significantly decreased at 16 weeks of age (in the group exposed to hyperoxia) 
but no significant difference was observed at 4 weeks of age, indicating a possible age-related or 
hypertension-related alteration in its expression. In addition, aconitase activity is significantly 
increased at 16 weeks of age in the hyperoxia exposed group, suggesting a protective effect. This 
increase was not seen at 4 weeks of age (possible change after onset of hypertension/ageing). 
Finally, ATP synthase β subunit (involved in ATP production) expression was found to be 
significantly increased at 16 weeks of age but not at 4 weeks of age, suggesting the possible role of 
secondary injury to mitochondria instead of a programming effect. Therefore, in females, there 
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seems to be evidence for both a programming effect and an effect possibly due to injury as a 
secondary effect to the development of hypertension. In males, the results seem to indicate more 
of an injury effect rather than a programming effect. Citric acid cycle enzymatic activity was 
significantly affected at 16 weeks of age, compared to no significant difference between groups at 
4 weeks of age. This trend was also observed for complex 4 and UCP2 protein expression in males. 
However, Prx3 expression seems to follow a programming effect. In males (exposed to hyperoxia) 
at 4 weeks of age, Prx3 expression was significantly increased as a possible short-term 
compensatory mechanism to deal with oxidative insult and significantly decreased at 16 weeks of 
age as Prx3 potentially becomes depleted or exhausted. 
 
3.4 Future Directions  
This study has demonstrated novel findings with regards to parameters of mitochondrial function 
in the kidney following neonatal oxygen exposure, including : ROS production, enzymatic activity 
and expression of key proteins involved in ATP production and antioxidant defense at 4 and 16 
weeks of age in both male and female rats. However, there still remains important studies to be 
done in order to fully describe and understand the effects of transient neonatal hyperoxia 
exposure on later life renal mitochondrial function.  
Future studies would include further tests to examine mitochondrial function (respiration/ATP 
production) and completing the evaluation of mitochondrial swelling (PTP opening) in females at 4 
weeks of age and in both genders at 16 weeks of age and repeating the NADPH/NADP+ assay. This 
study has assessed various aspects of mitochondrial metabolism in the kidney, however, it would 
be important to evaluate mitochondria in other tissues including the heart and brain, as 
mitochondria have been shown to respond differently in different tissues. It is especially important 
in the heart considering its role in hypertension and cardiovascular disease. In addition, evaluating 
mtDNA would be of interest since mtDNA has been shown to be reduced in the reprogramming of 
mitochondrial function in the development of type 2 diabetes190 and mtDNA has been shown to be 
sensitive to ROS damage191. Furthermore, future studies would include assessing animals at older 
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ages (12-24 months) to demonstrate long-term effects. Finally, evaluating the female cycle and the 
effects of estrogen could potentially allow different interpretation of the observed male/female 
differences. 
 
4.0 CONCLUSION 
Parameters of mitochondrial function in the kidney following a neonatal hyperoxic insult and its 
influence on young adults (4 weeks) and older adults (16 weeks) were evaluated throughout these 
studies. To our knowledge, this study is the first to comprehensively examine mitochondrial 
metabolism following transient neonatal hyperoxia exposure in male and female rats, both prior 
to and following the observed rise in blood pressure in this model. Importantly, we have shown 
that exposure to hyperoxia in the neonatal period results in mitochondrial dysfunction in the 
kidney in adulthood, with findings of altered enzymatic activity in the citric acid cycle, altered 
expression of antioxidants and of proteins involved in ATP production, as well as increased levels 
of H202. Preterm babies possess a diminished antioxidative capacity and are exposed upon birth to 
high oxygen concentrations relative to the intrauterine environment. Given the findings of the 
current study, this vulnerability to oxidative insults may also impact a vulnerability to 
mitochondrial dysfunction in individuals born preterm. Previous studies have demonstrated 
evidence for the possibility of ROS being a major contributor to developmental programming of 
adult diseases, such as the high blood pressure and renal disease observed in children and adults 
born preterm; however, the mechanisms remain unknown. Mitochondria are the major 
contributor of cellular ROS, and are involved in many processes (including ATP production and 
apoptosis) that have been shown to be adversely affected by ageing, indicating that they may play 
a role in the programming of adult diseases. The originality of this study is to also show for the first 
time, that there appears to be differences in mitochondrial metabolism in the kidneys between 
males and females following oxidative insult with the potential dual roles of programming 
(following the neonatal hyperoxia exposure) and injury (following the onset of hypertension) as a 
possible mechanism for the observed disease phenotype. Furthermore, the observed sex 
difference indicates that females may be better able to cope with oxidative insult than males, 
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which is a recognized fact in the neonatal period. Overall, the findings of this study have shown 
that neonatal hyperoxia exposure alters renal mitochondrial function in adulthood; however, 
future studies are required in order to deduce the mechanism responsible for the disease 
phenotype, and what exact role mitochondria may play in the programming of renal dysfunction 
and hypertension.  
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